JP2009124943A - New lactobacillus, lactobacillus composition and plant extract as well as method for producing plant extract and low molecular weight polyphenol - Google Patents
New lactobacillus, lactobacillus composition and plant extract as well as method for producing plant extract and low molecular weight polyphenol Download PDFInfo
- Publication number
- JP2009124943A JP2009124943A JP2007299592A JP2007299592A JP2009124943A JP 2009124943 A JP2009124943 A JP 2009124943A JP 2007299592 A JP2007299592 A JP 2007299592A JP 2007299592 A JP2007299592 A JP 2007299592A JP 2009124943 A JP2009124943 A JP 2009124943A
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- lactobacillus
- activity
- plant extract
- tannase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000419 plant extract Substances 0.000 title claims abstract description 43
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 25
- 150000008442 polyphenolic compounds Chemical class 0.000 title claims abstract description 24
- 235000013824 polyphenols Nutrition 0.000 title claims abstract description 24
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 241000186660 Lactobacillus Species 0.000 title abstract description 22
- 229940039696 lactobacillus Drugs 0.000 title abstract description 20
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 claims abstract description 145
- 230000000694 effects Effects 0.000 claims abstract description 99
- 108010038851 tannase Proteins 0.000 claims abstract description 77
- 229940074391 gallic acid Drugs 0.000 claims abstract description 60
- 235000004515 gallic acid Nutrition 0.000 claims abstract description 59
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 42
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 42
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 42
- 102000004031 Carboxy-Lyases Human genes 0.000 claims abstract description 36
- 108090000489 Carboxy-Lyases Proteins 0.000 claims abstract description 36
- 229920001202 Inulin Polymers 0.000 claims abstract description 25
- 229940029339 inulin Drugs 0.000 claims abstract description 25
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 24
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 250
- 241000894006 Bacteria Species 0.000 claims description 131
- 239000004310 lactic acid Substances 0.000 claims description 128
- 235000014655 lactic acid Nutrition 0.000 claims description 125
- 235000005487 catechin Nutrition 0.000 claims description 46
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 30
- 229950001002 cianidanol Drugs 0.000 claims description 29
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 25
- FBSFWRHWHYMIOG-UHFFFAOYSA-N methyl 3,4,5-trihydroxybenzoate Chemical compound COC(=O)C1=CC(O)=C(O)C(O)=C1 FBSFWRHWHYMIOG-UHFFFAOYSA-N 0.000 claims description 20
- 229920001461 hydrolysable tannin Polymers 0.000 claims description 14
- 230000003301 hydrolyzing effect Effects 0.000 claims description 14
- IBKQQKPQRYUGBJ-UHFFFAOYSA-N methyl gallate Natural products CC(=O)C1=CC(O)=C(O)C(O)=C1 IBKQQKPQRYUGBJ-UHFFFAOYSA-N 0.000 claims description 10
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 claims description 8
- 210000000936 intestine Anatomy 0.000 abstract description 18
- 239000000243 solution Substances 0.000 description 29
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 28
- 241000196324 Embryophyta Species 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 238000000605 extraction Methods 0.000 description 22
- 229920001864 tannin Polymers 0.000 description 19
- 235000018553 tannin Nutrition 0.000 description 19
- 239000001648 tannin Substances 0.000 description 19
- 150000001765 catechin Chemical class 0.000 description 14
- 229940079877 pyrogallol Drugs 0.000 description 14
- 238000012360 testing method Methods 0.000 description 12
- 239000002904 solvent Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- -1 flavonoid compounds Chemical class 0.000 description 10
- 244000269722 Thea sinensis Species 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 7
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 7
- 229920002079 Ellagic acid Polymers 0.000 description 7
- 235000004132 ellagic acid Nutrition 0.000 description 7
- 229960002852 ellagic acid Drugs 0.000 description 7
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 5
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940030275 epigallocatechin gallate Drugs 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 235000012149 noodles Nutrition 0.000 description 5
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 230000001771 impaired effect Effects 0.000 description 4
- 239000012046 mixed solvent Substances 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 235000021110 pickles Nutrition 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000013616 tea Nutrition 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 240000006439 Aspergillus oryzae Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 241000192001 Pediococcus Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 2
- WMBWREPUVVBILR-NQIIRXRSSA-N (-)-gallocatechin gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-NQIIRXRSSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 235000003130 Arctium lappa Nutrition 0.000 description 2
- 235000008078 Arctium minus Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 235000007516 Chrysanthemum Nutrition 0.000 description 2
- 240000005250 Chrysanthemum indicum Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 240000008620 Fagopyrum esculentum Species 0.000 description 2
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 241000186713 Lactobacillus amylovorus Species 0.000 description 2
- 240000001929 Lactobacillus brevis Species 0.000 description 2
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229940100688 oral solution Drugs 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XMOCLSLCDHWDHP-DOMZBBRYSA-N (-)-gallocatechin Chemical compound C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-DOMZBBRYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000962514 Alosa chrysochloris Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000473391 Archosargus rhomboidalis Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 244000294263 Arctium minus Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 1
- 241000237519 Bivalvia Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 235000005459 Digitaria exilis Nutrition 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001653 FEMA 3120 Substances 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208251 Gymnema Species 0.000 description 1
- 244000050907 Hedychium coronarium Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 241000186842 Lactobacillus coryniformis Species 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241000186673 Lactobacillus delbrueckii Species 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000186684 Lactobacillus pentosus Species 0.000 description 1
- 244000185256 Lactobacillus plantarum WCFS1 Species 0.000 description 1
- 235000011227 Lactobacillus plantarum WCFS1 Nutrition 0.000 description 1
- 241000186604 Lactobacillus reuteri Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000194034 Lactococcus lactis subsp. cremoris Species 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 241000192129 Leuconostoc lactis Species 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241001529735 Melissa Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000192134 Oenococcus oeni Species 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 241001282110 Pagrus major Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 241000500340 Pediococcus damnosus Species 0.000 description 1
- 241000191996 Pediococcus pentosaceus Species 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000722234 Pseudococcus Species 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000282941 Rangifer tarandus Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241001529742 Rosmarinus Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000014962 Streptococcus cremoris Nutrition 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000004552 Yucca aloifolia Nutrition 0.000 description 1
- 235000012044 Yucca brevifolia Nutrition 0.000 description 1
- 235000017049 Yucca glauca Nutrition 0.000 description 1
- 240000005780 Yucca gloriosa Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- PFTAWBLQPZVEMU-UHFFFAOYSA-N catechin Chemical compound OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UHFFFAOYSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 235000020639 clam Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940109738 hematin Drugs 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940001882 lactobacillus reuteri Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000006068 taste-masking agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 235000020681 well water Nutrition 0.000 description 1
- 239000002349 well water Substances 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本発明は、強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、腸で好適に定着でき、安全に摂取できる新規の乳酸菌、この乳酸菌を含む乳酸菌組成物及び植物エキス、並びに、この乳酸菌を用いる植物エキス及び低分子ポリフェノールの製造方法に関する。 The present invention is a novel lactic acid bacterium having strong tannase activity, having no gallic acid decarboxylase activity, being able to be suitably established in the intestine, and being able to be safely ingested, a lactic acid bacterium composition and plant extract containing this lactic acid bacterium, and The present invention relates to a plant extract using this lactic acid bacterium and a method for producing a low molecular weight polyphenol.
タンニンとは、植物起源のポリフェノールであって、タンパク質、塩基性物質、金属などと反応することで、水に対して難溶性の沈殿を生じる化合物群である。その作用としては、収斂作用、皮なめし作用をはじめとして、抗腫瘍作用、抗酸化作用など、様々な生理作用が知られている。タンニンは、その構造から、没食子酸やエラグ酸と糖とがエステル結合した加水分解型タンニン、及び、フラボノイド化合物などが重合した縮合型タンニンに大別される。 Tannins are plant-derived polyphenols that are a group of compounds that react with proteins, basic substances, metals, and the like to form precipitates that are sparingly soluble in water. As its action, various physiological actions such as an astringent action, a skin tanning action, an antitumor action and an antioxidant action are known. Tannins are roughly classified into hydrolyzable tannins in which gallic acid or ellagic acid and sugar are ester-bonded, and condensed tannins in which flavonoid compounds are polymerized.
カテキン類は縮合型タンニンの一種であり、その作用としては、抗腫瘍作用、抗酸化作用、抗老化作用、血圧降下作用など、様々な生理作用が知られている。カテキン類は、その構造から、ガロイル基を有するガレート型カテキンと、ガロイル基を有さない非ガレート型カテキンとに大別される。前記ガレート型カテキンとしては、エピガロカテキンガレート(EGCg)、エピカテキンガレート(ECg)、カテキンガレート(Cg)、ガロカテキンガレート(GCg)などが挙げられる。非ガレート型カテキンとしては、エピガロカテキン(EGC)、エピカテキン(EC)、カテキン(C)、ガロカテキン(GC)などが挙げられる。カテキン類は、緑茶に豊富に含まれることが知られている。
2005年の野菜茶葉研究所・機能解析部・茶品質化学研究室の報告によると、ガレート型カテキンは、ペクチンやタンパク質との反応性が高いことが示されている。また、茶を摂取した後のカテキン類のAUC(血中濃度−時間曲線下面積)が測定された結果、EGCに比べて、EGCgの方がAUCが低いことが報告されている(例えば、非特許文献1参照)。これらのことから、ガレート型カテキンは、ペクチンやタンパク質と複合体を形成することで、腸管からの吸収効率が低下していることが示唆される。
Catechins are a kind of condensed tannin, and various physiological actions such as antitumor action, antioxidant action, anti-aging action, and blood pressure lowering action are known. Catechins are roughly classified into gallate-type catechins having a galloyl group and non-gallate-type catechins having no galloyl group because of their structures. Examples of the gallate catechin include epigallocatechin gallate (EGCg), epicatechin gallate (ECg), catechin gallate (Cg), gallocatechin gallate (GCg) and the like. Non-gallate catechins include epigallocatechin (EGC), epicatechin (EC), catechin (C), gallocatechin (GC) and the like. Catechins are known to be abundant in green tea.
According to a report from the Vegetable Tea Leaf Research Institute, Functional Analysis Department, and Tea Quality Chemistry Laboratory in 2005, gallate-type catechins show high reactivity with pectin and proteins. Moreover, as a result of measuring AUC (area under the blood concentration-time curve) of catechins after ingesting tea, it has been reported that EGCg has lower AUC than EGC (for example, non- Patent Document 1). These facts suggest that gallate-type catechins have a reduced absorption efficiency from the intestinal tract by forming a complex with pectin and protein.
タンナーゼ(タンニンアシルヒドロラーゼ、EC3.1.1.20)は、加水分解型タンニンのエステル結合を加水分解する反応を触媒する酵素である。また、タンナーゼは、ガレート型カテキンのエステル結合を加水分解する反応も触媒する。タンナーゼは、糸状菌であるアスペルギルス・オリゼ、アスペルギルス・ニガーなどが有することが報告されている。 Tannase (tannin acylhydrolase, EC 3.1.1.20) is an enzyme that catalyzes a reaction of hydrolyzing the ester bond of hydrolyzed tannin. Tannase also catalyzes a reaction that hydrolyzes the ester bond of gallate catechin. It has been reported that tannase is contained in Aspergillus oryzae, Aspergillus niger and the like, which are filamentous fungi.
従来、乳酸菌は、タンナーゼ活性を有しないと考えられていたが、一部の乳酸菌がタンナーゼ活性を有することが報告された(例えば、特許文献1参照)。したがって、前記タンナーゼ活性を有する乳酸菌は、ガレート型カテキン及び加水分解型タンニンの吸収効率の向上を目的として、食品の製造時又は腸内においてガレート型カテキン及び加水分解性タンニンの加水分解に利用されることが期待されている。 Conventionally, lactic acid bacteria were thought to have no tannase activity, but some lactic acid bacteria were reported to have tannase activity (see, for example, Patent Document 1). Therefore, the lactic acid bacterium having tannase activity is used for hydrolysis of gallate catechin and hydrolyzable tannin during the production of food or in the intestine for the purpose of improving the absorption efficiency of gallate catechin and hydrolyzable tannin. It is expected that.
しかしながら、特許文献1に記載される乳酸菌は、タンナーゼ活性を有する一方で、没食子酸脱炭酸酵素活性も有している。没食子酸脱炭酸酵素は、没食子酸を脱炭酸し、ピロガロールを生成する酵素である。加水分解性タンニン又はガレート型カテキンをタンナーゼ処理した後に遊離される、没食子酸、エラグ酸などの低分子ポリフェノールは、抗酸化作用を有することが知られている。また、没食子酸とピロガロールとを比較すると、ピロガロールの方がDNA損傷能が高く、大腸癌の原因となりやすいことが、報告されている(例えば、特許文献2参照)。したがって、没食子酸、エラグ酸などの低分子ポリフェノールを生成でき、生成した没食子酸をピロガロールに変換しない乳酸菌が求められている。 However, the lactic acid bacteria described in Patent Document 1 have tannase activity, but also have gallic acid decarboxylase activity. Gallic acid decarboxylase is an enzyme that decarboxylates gallic acid to produce pyrogallol. It is known that low molecular weight polyphenols such as gallic acid and ellagic acid that are liberated after tannase treatment of hydrolyzable tannin or gallate-type catechin have an antioxidant effect. In addition, when gallic acid and pyrogallol are compared, it has been reported that pyrogallol has a higher DNA damage ability and is likely to cause colorectal cancer (see, for example, Patent Document 2). Accordingly, there is a need for a lactic acid bacterium that can produce low molecular weight polyphenols such as gallic acid and ellagic acid and that does not convert the produced gallic acid into pyrogallol.
近年、乳酸菌であるラクトバシルス・プランタラムにおいて、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さない株が報告された(例えば、非特許文献2、3参照)。前記非特許文献2、3によれば、上記の問題点を改善可能な乳酸菌株を提供することができる。
しかしながら、非特許文献2、3に記載の、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さないラクトバシルス・プランタラム株は、必ずしもタンナーゼ活性が強いものではない。
In recent years, a strain that has tannase activity and does not have gallic acid decarboxylase activity has been reported in Lactobacillus plantarum, which is a lactic acid bacterium (see, for example, Non-Patent Documents 2 and 3). According to the said nonpatent literatures 2 and 3, the lactic acid strain which can improve said problem can be provided.
However, the Lactobacillus plantarum strain described in Non-Patent Documents 2 and 3 that has tannase activity and does not have gallic acid decarboxylase activity does not necessarily have strong tannase activity.
一方、イヌリンは、主にフルクトースが重合した構造であって、胃や十二指腸では消化されずに腸まで到達し、腸内細菌の増殖に好適に利用されることから、効果的なプレバイオティクスとして注目されている。イヌリンは、チコリー、ニンニク、ゴボウなどに豊富に含有されており、近年では、健康食品などに添加されて利用されることも多い。したがって、イヌリン資化性を有している細菌は、腸内においてイヌリンを資化できるので、増殖・定着しやすくなる。このような性状は、例えば乳酸菌などの、腸内で有益とされる細菌に対して、強く求められている。
しかしながら、通常、ラクトバシルス・プランタラムは、イヌリン資化性が低いことが知られている(例えば、非特許文献2、4参照)。前記非特許文献2、3に記載の、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さないラクトバシルス・プランタラム株も、そのいずれもが、イヌリン資化性を有していない。
Inulin, on the other hand, is a structure in which fructose is mainly polymerized. It reaches the intestine without being digested in the stomach and duodenum, and is preferably used for the growth of intestinal bacteria. Attention has been paid. Inulin is abundantly contained in chicory, garlic, burdock and the like, and in recent years, it is often added to health foods. Therefore, a bacterium having inulin assimilation ability can assimilate inulin in the intestine, so that it is easy to grow and settle. Such properties are strongly sought for bacteria that are beneficial in the intestine, such as lactic acid bacteria.
However, it is generally known that Lactobacillus plantarum has low inulin assimilation properties (see, for example, Non-Patent Documents 2 and 4). None of the Lactobacillus plantarum strains described in Non-Patent Documents 2 and 3 that have tannase activity and do not have gallic acid decarboxylase activity have inulin assimilation properties.
したがって、強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、腸で好適に定着でき、安全に摂取できる新規の乳酸菌株は、未だ提供されておらず、その速やかな提供が強く求められているのが現状である。 Therefore, a new lactic acid strain that has strong tannase activity, does not have gallic acid decarboxylase activity, can be well established in the intestine, and can be safely ingested has not yet been provided, and its prompt provision is strong. The current situation is what is required.
本発明は、前記従来における諸問題を解決し、以下の目的を達成することを課題とする。即ち、本発明は、強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、腸で好適に定着でき、安全に摂取できる新規の乳酸菌、この乳酸菌を含む乳酸菌組成物及び植物エキス、並びに、この乳酸菌を用いる植物エキス及び低分子ポリフェノールの製造方法を提供することを目的とする。 An object of the present invention is to solve the conventional problems and achieve the following objects. That is, the present invention is a novel lactic acid bacterium having strong tannase activity, having no gallic acid decarboxylase activity, being able to be suitably established in the intestine, and being able to be taken safely, a lactic acid bacterium composition and a plant extract containing the lactic acid bacterium, And it aims at providing the manufacturing method of the plant extract and low molecular weight polyphenol which use this lactic acid bacteria.
前記課題を解決するため、本発明者らは鋭意検討した結果、以下のような知見を得た。即ち、漬物から単離された新規乳酸菌の性状を分析したところ、前記乳酸菌は強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、更にイヌリン資化性を有しており、そのため、前記乳酸菌は加水分解性タンニン及びガレート型カテキンを効果的に加水分解することができて、更に腸での定着に優れるので、植物エキスや医薬品などに添加する乳酸菌として、又は、植物エキスや低分子ポリフェノールの製造に用いる乳酸菌として、好適に利用できるという知見である。 In order to solve the above-mentioned problems, the present inventors have made extensive studies and as a result, obtained the following findings. That is, when the properties of a novel lactic acid bacterium isolated from pickles were analyzed, the lactic acid bacterium had a strong tannase activity, no gallic acid decarboxylase activity, and further an inulin assimilation property. The lactic acid bacteria can effectively hydrolyze hydrolysable tannin and gallate catechins, and are excellent in colonization in the intestines. This is a finding that it can be suitably used as a lactic acid bacterium used in the production of molecular polyphenols.
前記したように、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有する乳酸菌については既に報告されている。しかしながら、従来の乳酸菌に比べて強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、更にイヌリン資化性まで有する乳酸菌が存在することは従来全く知られておらず、本発明者らの新たな知見である。 As described above, lactic acid bacteria having tannase activity and gallic acid decarboxylase activity have already been reported. However, it has not been known at all that there are lactic acid bacteria having strong tannase activity compared to conventional lactic acid bacteria, no gallic acid decarboxylase activity, and even inulin assimilation ability. These are new findings.
本発明は、本発明者らによる前記知見に基づくものであり、前記課題を解決するための手段としては、以下の通りである。即ち、
<1> タンナーゼ活性を有し、かつ、没食子酸脱炭酸酵素活性を有さない乳酸菌であって、イヌリン資化性を有することを特徴とする乳酸菌。
<2> ラクトバシルス・プランタラムである<1>に記載の乳酸菌。
<3> ラクトバシルス・プランタラム 22A−1(FERM AP−21409)、ラクトバシルス・プランタラム 22A−3(FERM AP−21411)、ラクトバシルス・プランタラム 22B−2(FERM AP−21410)のうちいずれかである<2>に記載の乳酸菌。
<4> <1>から<3>のいずれかに記載の乳酸菌を含む乳酸菌組成物。
<5> <1>から<3>のいずれかに記載の乳酸菌と、植物からの抽出物とを含む植物エキス。
<6> <1>から<3>のいずれかに記載の乳酸菌を用いて、植物からの抽出物に含有されるガレート型カテキンを加水分解する工程を含む植物エキスの製造方法。
<7> 請求項1から3のいずれかに記載の乳酸菌を用いて、植物からの抽出物に含有される加水分解型タンニンを加水分解する工程を含む植物エキスの製造方法。
<8> <1>から<3>のいずれかに記載の乳酸菌を用いて、加水分解型タンニン、ガレート型カテキン及び没食子酸メチルのうち少なくとも1つを加水分解する工程を含む低分子ポリフェノールの製造方法。
The present invention is based on the above findings by the present inventors, and means for solving the above problems are as follows. That is,
<1> A lactic acid bacterium having tannase activity and not having gallic acid decarboxylase activity, wherein the lactic acid bacterium has an inulin assimilation property.
<2> The lactic acid bacterium according to <1>, which is Lactobacillus plantarum.
<3> Lactobacillus plantarum 22A-1 (FERM AP-21409), Lactobacillus plantarum 22A-3 (FERM AP-21411), or Lactobacillus plantarum 22B-2 (FERM AP-21410) The lactic acid bacterium according to <2>.
<4> A lactic acid bacterium composition comprising the lactic acid bacterium according to any one of <1> to <3>.
<5> A plant extract comprising the lactic acid bacterium according to any one of <1> to <3> and an extract from a plant.
<6> A method for producing a plant extract, comprising a step of hydrolyzing a gallate catechin contained in an extract from a plant using the lactic acid bacterium according to any one of <1> to <3>.
<7> A method for producing a plant extract comprising a step of hydrolyzing hydrolyzable tannin contained in an extract from a plant using the lactic acid bacterium according to any one of claims 1 to 3.
<8> Production of a low molecular weight polyphenol comprising a step of hydrolyzing at least one of hydrolyzed tannin, gallate catechin and methyl gallate using the lactic acid bacterium according to any one of <1> to <3> Method.
本発明によると、従来における諸問題を解決することができ、強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、腸で好適に定着でき、安全に摂取できる新規の乳酸菌、この乳酸菌を含む乳酸菌組成物及び植物エキス、並びに、この乳酸菌を用いる植物エキス及び低分子ポリフェノールの製造方法を提供することができる。 According to the present invention, various conventional problems can be solved, a novel lactic acid bacterium having a strong tannase activity, no gallic acid decarboxylase activity, suitable for colonization in the intestine, and safe ingestion, It is possible to provide a lactic acid bacteria composition and a plant extract containing lactic acid bacteria, and a method for producing a plant extract and a low molecular weight polyphenol using the lactic acid bacteria.
(乳酸菌)
本発明の乳酸菌は、タンナーゼ活性を有し、かつ、没食子酸脱炭酸酵素活性を有さない乳酸菌であって、イヌリン資化性を有することを特徴とし、更に必要に応じてその他の性状を有する。
(Lactic acid bacteria)
The lactic acid bacterium of the present invention is a lactic acid bacterium having tannase activity and not having gallic acid decarboxylase activity, characterized by having inulin assimilation properties, and further having other properties as required. .
−タンナーゼ活性−
前記タンナーゼ活性とは、加水分解型タンニンのエステル結合を加水分解する反応を触媒する活性である。加水分解型タンニンにおいてエステル結合が加水分解されると、通常、没食子酸、エラグ酸などの低分子ポリフェノールが遊離する。
また、前記タンナーゼ活性は、ガレート型カテキンのエステル結合を加水分解する反応も触媒する活性である。ガレート型カテキンにおいてエステル結合が加水分解されると、通常、ガレート型カテキンが非ガレート型カテキンに変換されるとともに、没食子酸が遊離する。
-Tannase activity-
The tannase activity is an activity that catalyzes a reaction of hydrolyzing the ester bond of hydrolyzed tannin. When the ester bond is hydrolyzed in the hydrolyzed tannin, low molecular weight polyphenols such as gallic acid and ellagic acid are usually released.
The tannase activity is also an activity that catalyzes a reaction of hydrolyzing the ester bond of gallate catechin. When an ester bond is hydrolyzed in gallate catechin, gallate catechin is usually converted into non-gallate catechin and gallic acid is released.
前記乳酸菌がタンナーゼ活性を有しているか否かを調べる方法としては、特に制限はないが、没食子酸メチルを基質として反応させ、反応産物である没食子酸を検出する方法が一般的である。前記没食子酸を検出する方法としては、特に制限はなく、例えば、HPLC(高性能液体クロマトグラフィー)や質量分析計を用いて検出したり、遊離した没食子酸に由来する緑色乃至茶色への呈色を、分光光度計を用いて又は目視により検出したりすることができる。 A method for examining whether or not the lactic acid bacterium has tannase activity is not particularly limited, but a method of detecting gallic acid as a reaction product by reacting methyl gallate as a substrate is common. The method for detecting gallic acid is not particularly limited. For example, it can be detected using HPLC (High Performance Liquid Chromatography) or a mass spectrometer, or can be colored from green to brown derived from liberated gallic acid. Can be detected using a spectrophotometer or visually.
前記没食子酸に由来する緑色乃至茶色への呈色を利用した、タンナーゼ活性の定量方法としては、例えば、Nishitaniらの論文(Nishitani,Y.,Osawa,R.(2003) A novel colorimetric method to quantify tannase activity of viable bacteria. Journal of Microbiological Methods 54(2):281−284.)に詳細に記載されている。 As a method for quantifying tannase activity using the coloration from green to brown derived from gallic acid, for example, a paper by Nishitani et al. (Nishitani, Y., Osawa, R. (2003) A novel colorimetric method to quantify) tannase activity of viable bacteria.Journal of Microbiological Methods 54 (2): 281-284.).
前記乳酸菌が有するタンナーゼ活性の強さとしては、特に制限はなく、目的に応じて適宜選択することができるが、前記Nishitaniらの論文に記載のタンナーゼ活性の定量方法により測定した場合には、2.0mU/mL以上が好ましく、6.0mU/mL以上が特に好ましい。前記タンナーゼ活性の強さが2.0mU/mL以上であると、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有する公知の乳酸菌と比べて、タンナーゼ活性が強い点で好ましい。前記タンナーゼ活性の強さが6.0mU/mL以上であると、タンナーゼ活性を有する公知の乳酸菌と比べて、タンナーゼ活性が強い点で好ましい。 The strength of tannase activity possessed by the lactic acid bacteria is not particularly limited and can be appropriately selected according to the purpose. However, when measured by the tannase activity quantification method described in the Nishitani et al. 0.0 mU / mL or more is preferable, and 6.0 mU / mL or more is particularly preferable. It is preferable that the strength of the tannase activity is 2.0 mU / mL or more from the viewpoint that the tannase activity is stronger than the known lactic acid bacteria having tannase activity and gallic acid decarboxylase activity. It is preferable that the tannase activity is 6.0 mU / mL or more in terms of strong tannase activity as compared with known lactic acid bacteria having tannase activity.
−没食子酸脱炭酸酵素活性−
前記没食子酸脱炭酸酵素活性とは、没食子酸を脱炭酸し、ピロガロールを生成する活性を意味する。
前記乳酸菌が没食子酸脱炭酸酵素活性を有しているか否かを調べる方法としては、特に制限はないが、没食子酸を基質として反応させ、反応産物であるピロガロールを検出する方法が一般的である。前記ピロガロールを検出する方法としては、特に制限はなく、例えば、HPLCや質量分析計を用いて生成したピロガロールを検出したり、生成したピロガロールに由来する橙色への呈色を、分光光度計を用いて又は目視により検出したりすることができる。
-Gallic acid decarboxylase activity-
The gallic acid decarboxylase activity means an activity of decarboxylating gallic acid to generate pyrogallol.
The method for examining whether or not the lactic acid bacterium has gallic acid decarboxylase activity is not particularly limited, but a general method is to react with gallic acid as a substrate and detect pyrogallol as a reaction product. . The method for detecting pyrogallol is not particularly limited. For example, pyrogallol generated using HPLC or a mass spectrometer is detected, or coloration to orange derived from the generated pyrogallol is performed using a spectrophotometer. Or can be detected visually.
−イヌリン資化性−
前記イヌリン資化性とは、イヌリンを炭素源として増殖できることを意味する。
前記乳酸菌がイヌリン資化性を有しているか否かを調べる方法としては、特に制限はないが、イヌリンのみを炭素源として添加した寒天培地に前記乳酸菌を播種し、その生育を観察する方法が挙げられる。また、前記イヌリン資化性の有無は、例えば、市販されている細菌同定キットを利用して簡便に調べることができる。
-Inulin utilization-
The inulin assimilation means that it can be grown using inulin as a carbon source.
A method for examining whether or not the lactic acid bacterium has inulin assimilation is not particularly limited, but there is a method of inoculating the lactic acid bacterium on an agar medium containing only inulin as a carbon source and observing its growth. Can be mentioned. In addition, the presence or absence of the inulin assimilation can be easily examined using, for example, a commercially available bacterial identification kit.
−乳酸菌−
前記乳酸菌としては、特に制限はなく、発酵により乳酸を産生することができる細菌の中から、タンナーゼ活性を有し、かつ、没食子酸脱炭酸酵素活性を有さず、イヌリン資化性を有する細菌を、目的に応じて適宜選択することができる。前記乳酸菌としては、例えば、ラクトバシルス属(Lactobacillus)、ペディオコッカス属(Pediococcus)、ビフィドバクテリウム属(Bifidobacterium)、ラクトコッカス属(Lactococcus)、リューコノストック属(Leuconostoc)、エンテロコッカス属(Enterococcus)に属する細菌などが挙げられる。
-Lactic acid bacteria-
The lactic acid bacterium is not particularly limited and is a bacterium that has tannase activity and does not have gallic acid decarboxylase activity and has inulin assimilation ability among bacteria that can produce lactic acid by fermentation. Can be appropriately selected according to the purpose. Examples of the lactic acid bacteria include, for example, Lactobacillus, Pediococcus, Bifidobacterium, Lactococcus, Leuconostoc, and Enterococcus cc. And bacteria belonging to
前記乳酸菌の種としては、例えば、ラクトバシルス属として、ラクトバシルス プランタラム(Lactobacillus plantarum)、ラクトバシルス サリバリウス(Lactobacillus salivalius)、ラクトバシルス アミロボラス(Lactobacillus amylovorus)、ラクトバシルス カゼイ(Lactobacillus casei)、ラクトバチル キタサトニス(Lactobacillus kitasatonisi)、ラクトバチル ロイテリ(Lactobacillus reuteri)、ラクトバチル ジョンソニ(Lactobacillus jhonsonii)、ラクトバシルス アシドフィラス(Lactobacillus acidophilus)、ラクトバシルス ブレビス(Lactobacillus brevis)、ラクトバシルス コリニホルミス(Lactobacillus coryniformis)、ラクトバシルス カルバタス(Lactobacillus curvatus)、ラクトバシルス デルブリュキィ(Lactobacillus delbrueckii)、ラクトバシルス ファルシミナス(Lactobacillus farciminus)、ラクトバシルス ラムノサス(Lactobacillus rhamnosus);ペディオコッカス属として、ペディオコッカス ダムノサス(Pediococcus damnosusu)、ペディオコッカス ハロフィラス(Pediococcus halophilus)、ペディオコッカス パルバラス(Pediococcus parvulus)、ペディオコッカス ペントサセウス(Pediococcus pentosaceus);ビフィドバクテリウム属として、ビフィドバクテリウム アドレセンティス(Bifidobacterium adolescentis)、ビフィドバクテリウム ビフィダス((Bifidobacterium bifidus);ラクトコッカス属として、ラクトコッカス クレモリス(Lactococcus cremoris)、ラクトコッカス ラクティス(Lactococcus lactis);リューコノストック属として、リューコノストック エノス(Leuconostoc oenos)、リューコノストック ラクティス(Leuconostoc lactis)、リューコノストック メセンテロイデス(Leuconostoc mesenteroides);エンテロコッカス属として、エンテロコッカス フェカリス(Enterococcus faecalis)などが挙げられる。中でも、効率よく増殖し、得られた発酵物の活性が強い点で、ラクトバシルス プランタラム(Lactobacillus plantarum)が特に好ましい。 The seeds of the lactic acid bacteria, e.g., as Lactobacillus, Lactobacillus plantarum (Lactobacillus plantarum), Lactobacillus salivarius (Lactobacillus salivalius), Lactobacillus amylovorus (Lactobacillus amylovorus), Lactobacillus casei (Lactobacillus casei), Rakutobachiru Kitasatonisu (Lactobacillus kitasatonisi), Rakutobachiru Reuteri (Lactobacillus reuteri), Lactobacillus johnsonii (Lactobacillus jhonsonii), Lactobacillus acidophilus (Lactobacillus acidophilus) ), Lactobacillus brevis (Lactobacillus brevis), Lactobacillus Korinihorumisu (Lactobacillus coryniformis), Lactobacillus Karubatasu (Lactobacillus curvatus), Lactobacillus Deruburyukyi (Lactobacillus delbrueckii), Lactobacillus Fal'cie Minas (Lactobacillus farciminus), Lactobacillus rhamnosus (Lactobacillus rhamnosus); as Pediococcus sp Pediococcus damnosus, Pediococcus halophyllus, Pedio Pseudococcus parvulus, Pediococcus pentosaceus; Bifidobacterium as Bifidobacterium adolescentes, Bifidobium fid Lactococcus cremoris, Lactococcus lactis; as the genus Leuconostoc, Leuconostoc oenos, Leuconostoc lactis (Leuconostost) lactis), Leuconostoc mesenteroides (Leuconostoc mesenteroides); as Enterococcus, and the like Enterococcus faecalis (Enterococcus faecalis). Among them, Lactobacillus plantarum is particularly preferable because it proliferates efficiently and the activity of the obtained fermented product is strong.
前記ラクトバシルス・プランタラムとしては、特に制限はなく、目的に応じて適宜選択することができるが、ラクトバシルス・プランタラム 22A−1(FERM AP−21409)、ラクトバシルス・プランタラム 22A−3(FERM AP−21411)、ラクトバシルス・プランタラム 22B−2(FERM AP−21410)のうちいずれかが特に好ましい。 There is no restriction | limiting in particular as said Lactobacillus plantarum, Although it can select suitably according to the objective, Lactobacillus plantarum 22A-1 (FERM AP-21409), Lactobacillus plantarum 22A-3 (FERM AP- 21411) and Lactobacillus plantarum 22B-2 (FERM AP-21410) are particularly preferred.
−22A−1株、22A−3株及び22B−2株−
前記ラクトバシルス・プランタラム 22A−1(FERM AP−21409)、ラクトバシルス・プランタラム 22A−3(FERM AP−21411)、ラクトバシルス・プランタラム 22B−2(FERM AP−21410)の3株は、本発明者らにより漬物から単離・同定された株であり、独立行政法人産業技術総合研究所 特許生物寄託センターに寄託されている。
-22A-1 strain, 22A-3 strain and 22B-2 strain-
Three strains of Lactobacillus plantarum 22A-1 (FERM AP-21409), Lactobacillus plantarum 22A-3 (FERM AP-21411), and Lactobacillus plantarum 22B-2 (FERM AP-21410) are the present inventors. Is a strain isolated and identified from pickles and deposited at the Patent Organism Depositary, National Institute of Advanced Industrial Science and Technology.
前記ラクトバシルス・プランタラム 22A−1は、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、イヌリン資化性を有する。前記ラクトバシルス・プランタラム 22A−1のタンナーゼ活性は、前記Nishitaniらの論文に記載のタンナーゼ定量方法により測定した結果、6.64mU/mLであった。
前記ラクトバシルス・プランタラム 22A−3は、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、イヌリン資化性を有する。前記ラクトバシルス・プランタラム 22A−3のタンナーゼ活性は、前記Nishitaniらの論文に記載のタンナーゼ定量方法により測定した結果、7.18mU/mLであった。
前記ラクトバシルス・プランタラム 22B−2は、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、イヌリン資化性を有する。前記ラクトバシルス・プランタラム 22B−2のタンナーゼ活性は、前記Nishitaniらの論文に記載のタンナーゼ定量方法により測定した結果、6.95mU/mLであった。
The Lactobacillus plantarum 22A-1 has tannase activity, does not have gallic acid decarboxylase activity, and has inulin utilization. The tannase activity of Lactobacillus plantarum 22A-1 was 6.64 mU / mL as a result of measurement by the tannase quantification method described in the above-mentioned article of Nishitani et al.
The Lactobacillus plantarum 22A-3 has tannase activity, does not have gallic acid decarboxylase activity, and has inulin utilization. The tannase activity of the Lactobacillus plantarum 22A-3 was 7.18 mU / mL as a result of measurement by the tannase quantification method described in the above-mentioned article by Nishitani et al.
The Lactobacillus plantarum 22B-2 has tannase activity, does not have gallic acid decarboxylase activity, and has inulin utilization. The tannase activity of the Lactobacillus plantarum 22B-2 was 6.95 mU / mL as a result of measurement by the tannase quantification method described in the above-mentioned article by Nishitani et al.
前記ラクトバシルス・プランタラム 22A−1(FERM AP−21409)、ラクトバシルス・プランタラム 22A−3(FERM AP−21411)、ラクトバシルス・プランタラム 22B−2(FERM AP−21410)の3株の菌学的性質を、下記表1及び表2に示す。なお、表2においては、前記3株の比較対象として、公知のラクトバシルス・プランタラム ATCC 14917の糖の分解性も併せて示す。 Bacteriological properties of the three strains of Lactobacillus plantarum 22A-1 (FERM AP-21409), Lactobacillus plantarum 22A-3 (FERM AP-21411), and Lactobacillus plantarum 22B-2 (FERM AP-21410) Are shown in Table 1 and Table 2 below. In Table 2, the sugar degradability of known Lactobacillus plantarum ATCC 14917 is also shown as a comparison target of the three strains.
(+:陽性、−:陰性)
(+: Positive,-: negative)
(植物エキス)
本発明の植物エキスは、前記乳酸菌と、植物からの抽出物とを含み、更に必要に応じてその他の成分を含有してなる。
(Plant extract)
The plant extract of this invention contains the said lactic acid bacteria and the extract from a plant, and also contains another component as needed.
−乳酸菌−
前記植物エキスにおける前記乳酸菌としては、特に制限はなく、前記した本発明の乳酸菌の項目で記載した乳酸菌の中から適宜選択することができる。前記乳酸菌は、1種単独で使用してもよいし、2種以上を併用してもよい。前記乳酸菌組成物における前記乳酸菌の含有量としては、特に制限はなく、目的に応じて適宜選択することができる。
-Lactic acid bacteria-
There is no restriction | limiting in particular as said lactic acid bacteria in the said plant extract, It can select suitably from the lactic acid bacteria described in the item of the lactic acid bacteria of the above-mentioned this invention. The said lactic acid bacteria may be used individually by 1 type, and may use 2 or more types together. There is no restriction | limiting in particular as content of the said lactic acid bacteria in the said lactic acid bacteria composition, According to the objective, it can select suitably.
−植物からの抽出物−
前記植物としては、特に制限はなく、目的に応じて適宜選択することができるが、ガレート型カテキン、加水分解型タンニンを含有することが好ましく、ガレート型カテキンを含有することが特に好ましい。
前記ガレート型カテキンとしては、特に制限はなく、例えば、エピガロカテキンガレート(EGCg)、エピカテキンガレート(ECg)、カテキンガレート(Cg)、ガロカテキンガレート(GCg)などが挙げられる。
-Extracts from plants-
There is no restriction | limiting in particular as said plant, Although it can select suitably according to the objective, It is preferable to contain a gallate type catechin and hydrolyzable tannin, and it is especially preferable to contain a gallate type catechin.
There is no restriction | limiting in particular as said gallate type catechin, For example, epigallocatechin gallate (EGCg), epicatechin gallate (ECg), catechin gallate (Cg), gallocatechin gallate (GCg) etc. are mentioned.
前記植物としては、例えば、アザミ、アマチャ、アヘン、アロエベア、イチョウ、ウイキョウ、ウコン、ウスベニアオイ、ウラジロガシ、エイジツ、エゾウコギ、延命草、黄精、オウギ、オウゴン、オウバク、大麦、オトギリ草、柿、カミツレ、甘草、キダチアロエ、ギムネマ、キャベツ、玉竹、キラヤ、金銀花、菊花、クコ、紅参、苦参、熊笹、クワ、月桂樹葉、決明子、ゲンチアナ、小麦、米、ゴボウ、ゴマ、サルビア、サンザ、紫蘇、サンシシ、サンシュ、山椒、山薬、椎茸、紫恨、芍薬、車前草、十薬、生姜、白樺、スギナ、ステビア、センキュウ、センナ、センブリ、ソバ、大根、タイソウ、大豆、タマリンド、タラ、チンピ、甜茶、テンニンカ、当帰、トチュウ、冬虫夏草、トウモロコシ、刺梨、人参、忍冬、パセリ、浜防風、ハマメリス、姫松茸、ビルベリー、ビワ、ブクリョウ、ブドウ、ブルーベリー、ヘチマ、ヘマティン、菩提樹、牡丹皮、ホップ、松葉、桃、メリッサ、ユッカ、ヨクイニン、ヨモギ、ライ麦、ラカンカ、緑茶、リンゴ、ルイボス、ルスカス、霊芝、連銭草、ローズヒップ、ローズマリー、ワレモコウ等が挙げられる。中でも、ガレート型カテキンを豊富に含んでいる点で、緑茶が好ましい。 Examples of the plant include a thistle, an acha, an opium, an aloe bear, a ginkgo, a fennel, a turmeric, a common beetle, a larva, an age, an elephant, a life-prolonging grass, a yellow spirit, an oat, an ogon, an oak, a barley, a hypericum grass, a cocoon, a chamomile, and a licorice. , Kidachi Aloe, Gymnema, Cabbage, Jade Bamboo, Kiraya, Gold and Silver Flower, Chrysanthemum, Chrysanthemum, Red Ginseng, Ginseng, Kumagusu, Mulberry, Laurel Leaves, Akiko, Gentiana, Wheat, Rice, Burdock, Sesame, Salvia, Sanza, Shiso, Sanshishi, Sanche, Yam, Yamayaku, Shiitake mushrooms, Purple candy, Glaze, Car forage, Ten ginseng, White ginger, Horsetail, Stevia, Cyprus, Senna, Assembly, Buckwheat, Radish, Taiso, Soy, Tamarind, Cod, Chimpi, Green tea , Tenninka, Tokachi, Tochu, Cordyceps, Corn, Sashimi, Ginseng, Shinobyu, Parsley, Beach windbreak, Mamellisu, himematsu mushroom, bilberry, loquat, bukuro, grape, blueberry, loofah, hematin, linden tree, peony, hops, pine needles, peaches, melissa, yucca, yokoinin, mugwort, rye, lakanka, green tea, apple, rooibos, lucas, Examples include ganoderma, reindeer grass, rose hips, rosemary, and bitumen. Among these, green tea is preferable because it contains abundant gallate catechins.
前記植物からの抽出物は、植物の抽出に一般に用いられている方法により容易に得ることができる。なお、前記植物からの抽出物には、植物の抽出液、該抽出液の希釈液を乾燥して得られる乾燥物、又はこれらの粗精製物もしくは精製物のいずれもが含まれる。 The plant extract can be easily obtained by a method generally used for plant extraction. The extract from the plant includes a plant extract, a dried product obtained by drying a diluted solution of the extract, or a crude product or a purified product thereof.
前記植物の抽出原料としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、植物の葉部、茎部、花(蕾)部、種子、(これらを地上部という)、根部などを用いることができる。 The plant extraction raw material is not particularly limited and may be appropriately selected depending on the purpose. For example, a plant leaf part, a stem part, a flower (bud) part, a seed (these are referred to as above-ground parts), A root or the like can be used.
前記抽出原料である植物は、乾燥した後、そのまま又は粗砕機を用い粉砕して溶媒抽出に供することにより得ることができる。乾燥は天日で行ってもよいし、通常使用されている乾燥機を用いて行ってもよい。なお、前記植物は、ヘキサン、ベンゼン等の非極性溶媒によって脱脂等の前処理を施してから抽出原料として使用してもよい。なお、脱脂等の前処理を行うことにより、植物の極性溶媒による抽出処理を効率よく行うことができる。 The plant that is the raw material for extraction can be obtained by drying or pulverizing it as it is or using a crusher and subjecting it to solvent extraction. Drying may be performed in the sun or using a commonly used dryer. The plant may be used as a raw material for extraction after pretreatment such as degreasing with a nonpolar solvent such as hexane or benzene. In addition, the extraction process by the polar solvent of a plant can be performed efficiently by performing pretreatments, such as degreasing.
前記抽出に用いる溶媒としては、水、親水性有機溶媒、又はこれらの混合溶媒を室温乃至溶媒の沸点以下の温度で用いることが好ましい。
前記抽出溶媒として使用し得る水としては、例えば、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水等の他、これらに各種処理を施したものが含まれる。水に施す処理としては、例えば、精製、加熱、殺菌、ろ過、イオン交換、浸透圧の調整、緩衝化等が含まれる。なお、前記抽出溶媒として使用し得る水には、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等も含まれる。
As the solvent used for the extraction, it is preferable to use water, a hydrophilic organic solvent, or a mixed solvent thereof at a temperature from room temperature to the boiling point of the solvent.
Examples of water that can be used as the extraction solvent include pure water, tap water, well water, mineral spring water, mineral water, hot spring water, spring water, fresh water, and the like, as well as water that has been subjected to various treatments. Examples of the treatment applied to water include purification, heating, sterilization, filtration, ion exchange, adjustment of osmotic pressure, buffering, and the like. The water that can be used as the extraction solvent includes purified water, hot water, ion exchange water, physiological saline, phosphate buffer, phosphate buffered saline, and the like.
前記親水性有機溶媒としては、例えば、メタノール、エタノール、プロピルアルコール、イソプロピルアルコール等の炭素数1〜5の低級アルコール;アセトン、メチルエチルケトン等の低級脂肪族ケトン;1,3−ブチレングリコール、プロピレングリコール、グリセリン等の炭素数2〜5の多価アルコールなどが挙げられ、これら親水性有機溶媒と水との混合溶媒などを用いることができる。
なお、前記水と親水性有機溶媒との混合溶媒を使用する場合には、低級アルコールの場合は水10質量部に対して1質量部〜90質量部、低級脂肪族ケトンの場合は水10質量部に対して1質量部〜40質量部添加することが好ましい。多価アルコールの場合は水10質量部に対して1質量部〜90質量部添加することが好ましい。
Examples of the hydrophilic organic solvent include lower alcohols having 1 to 5 carbon atoms such as methanol, ethanol, propyl alcohol, and isopropyl alcohol; lower aliphatic ketones such as acetone and methyl ethyl ketone; 1,3-butylene glycol, propylene glycol, Examples thereof include polyhydric alcohols having 2 to 5 carbon atoms such as glycerin, and a mixed solvent of these hydrophilic organic solvents and water can be used.
In addition, when using the mixed solvent of the said water and a hydrophilic organic solvent, in the case of a lower alcohol, 1 mass part-90 mass parts with respect to 10 mass parts of water, and in the case of a lower aliphatic ketone, 10 masses of water. It is preferable to add 1 to 40 parts by mass with respect to parts. In the case of polyhydric alcohol, it is preferable to add 1 part by mass to 90 parts by mass with respect to 10 parts by mass of water.
本発明において、抽出原料である植物から抽出物を抽出するにあたって、特殊な抽出方法を採用する必要はなく、室温又は還流加熱下で、任意の抽出装置を用いて抽出することができる。 In the present invention, when extracting an extract from a plant as an extraction raw material, it is not necessary to adopt a special extraction method, and the extraction can be performed using an arbitrary extraction device at room temperature or under reflux heating.
具体的には、抽出溶媒を満たした処理槽内に、抽出原料としての植物を投入し、更に必要に応じて時々攪拌しながら、30分間〜2時間静置して可溶性成分を溶出した後、ろ過して固形物を除去し、得られた抽出液から抽出溶媒を留去し、乾燥することにより抽出物が得られる。抽出溶媒量は通常、抽出原料の5〜15倍量(質量比)である。抽出条件は、抽出溶媒として水を用いた場合には、通常50℃〜95℃にて1〜4時間程度である。また、抽出溶媒として水とエタノールとの混合溶媒を用いた場合には、通常40℃〜80℃にて30分間〜4時間程度である。なお、溶媒で抽出することにより得られる抽出液は、抽出溶媒が安全性の高いものであれば、前記乳酸菌を添加した後に、そのまま本発明の植物エキスとして用いることができる。 Specifically, in a treatment tank filled with the extraction solvent, the plant as an extraction raw material is added, and further, with occasional stirring as necessary, after standing for 30 minutes to 2 hours to elute soluble components, The solid matter is removed by filtration, and the extraction solvent is distilled off from the obtained extract, and the extract is obtained by drying. The amount of the extraction solvent is usually 5 to 15 times (mass ratio) of the extraction raw material. The extraction conditions are usually about 1 to 4 hours at 50 to 95 ° C. when water is used as the extraction solvent. Moreover, when the mixed solvent of water and ethanol is used as an extraction solvent, it is normally 30 minutes-about 4 hours at 40 to 80 degreeC. In addition, the extraction liquid obtained by extracting with a solvent can be used as it is as the plant extract of the present invention after adding the lactic acid bacteria, as long as the extraction solvent is highly safe.
得られる植物の抽出液は、該抽出液の希釈液若しくは濃縮液、該抽出液の乾燥物、又はこれらの粗精製物若しくは精製物を得るため、常法に従って希釈、濃縮、乾燥、精製等の処理を施してもよい。 The obtained plant extract is diluted, concentrated, dried, purified, etc. according to a conventional method in order to obtain a diluted or concentrated solution of the extract, a dried product of the extract, or a crudely purified product or purified product thereof. Processing may be performed.
前記植物エキスは、前記植物からの抽出物を含有するので、前記植物からの抽出物が有する様々な生理作用を発揮することができる。
前記植物からの抽出物がタンニン及びカテキン類のうち少なくとも1つを含有する場合には、前記植物エキスは、タンニン及びカテキン類のうち少なくとも1つが有する生理作用を発揮することができる。前記タンニン及びカテキン類のうち少なくとも1つが有する生理作用としては、特に制限はなく、例えば、抗腫瘍作用、抗酸化作用、抗老化作用、血圧降下作用などが挙げられる。
更に、前記植物エキスは、強いタンナーゼ活性を有する前記乳酸菌を含むので、加水分解型タンニンが加水分解されてなる腸管吸収に優れたタンニン、及び、ガレート型カテキンが加水分解されてなる腸管吸収に優れたカテキン類のうち、少なくとも1つを豊富に含有する。したがって、前記植物エキスは、タンニン及びカテキン類が有する生理作用を、生体内において一層効果的に発揮することができる。
Since the plant extract contains an extract from the plant, it can exert various physiological actions that the extract from the plant has.
When the extract from the plant contains at least one of tannin and catechins, the plant extract can exert a physiological action possessed by at least one of tannin and catechins. The physiological action of at least one of the tannins and catechins is not particularly limited, and examples thereof include an antitumor action, an antioxidant action, an anti-aging action, and a blood pressure lowering action.
Furthermore, since the plant extract contains the lactic acid bacteria having strong tannase activity, the tannin excellent in intestinal absorption obtained by hydrolysis of hydrolyzable tannin and the intestinal absorption obtained by hydrolysis of gallate catechin are excellent. Abundantly contains at least one of the catechins. Therefore, the said plant extract can exhibit more effectively the physiological effect which tannin and catechin have.
また、前記植物エキスは、強いタンナーゼ活性を有する前記乳酸菌を含むので、加水分解型タンニン及びガレート型カテキンのうち少なくとも1つが加水分解されたときに生じる、没食子酸、エラグ酸などの低分子ポリフェノールを、豊富に含有する。したがって、前記植物エキスは、前記低分子ポリフェノールが有する生理作用を発揮することができる。前記低分子ポリフェノールが有する生理作用としては、特に制限はなく、例えば、抗酸化作用などが挙げられる。なお、前記植物エキスに含まれる前記乳酸菌が、没食子酸脱炭酸酵素活性を有しておらず、没食子酸をピロガロールに変換しないことも、前記植物エキスに低分子ポリフェノールが豊富に含まれる理由の一つとして挙げられる。
また、前記植物エキスに含有される乳酸菌は、イヌリン資化性を有しているので、植物エキスが経口摂取された後に、乳酸菌が腸内で増殖・定着して、腸内細菌叢を改善することができる。
In addition, since the plant extract contains the lactic acid bacterium having strong tannase activity, low molecular polyphenols such as gallic acid and ellagic acid produced when at least one of hydrolyzed tannin and gallate catechin is hydrolyzed. Contains abundantly. Therefore, the plant extract can exert the physiological action of the low molecular weight polyphenol. There is no restriction | limiting in particular as a physiological effect which the said low molecular polyphenol has, For example, an antioxidant effect etc. are mentioned. Note that the lactic acid bacteria contained in the plant extract does not have gallic acid decarboxylase activity and does not convert gallic acid into pyrogallol. As one.
Moreover, since the lactic acid bacteria contained in the plant extract have inulin assimilation properties, the lactic acid bacteria grow and settle in the intestine after the plant extract is taken orally, thereby improving the intestinal bacterial flora. be able to.
前記植物エキスの使用方法としては、特に制限はなく、食品、医薬、化合物の製造など分野を問わず幅広く利用することができ、例えば、そのまま経口摂取したり、既成の食品に添加する添加剤として利用したり、没食子酸やエラグ酸などの低分子ポリフェノールの精製原料として利用したりすることができる。 The method for using the plant extract is not particularly limited, and can be widely used regardless of the field of food, medicine, compound production, etc. For example, as an additive to be taken orally or added to a ready-made food It can be used as a raw material for purifying low molecular weight polyphenols such as gallic acid and ellagic acid.
前記食品としては、特に制限はなく、目的に応じて適宜選定することができるが、例えば、茶飲料、清涼飲料、炭酸飲料、栄養飲料、果実飲料、乳酸飲料等の飲料;アイスクリーム、アイスシャーベット、かき氷等の冷菓;そば、うどん、はるさめ、ぎょうざの皮、しゅうまいの皮、中華麺、即席麺等の麺類;飴、キャンディー、ガム、チョコレート、錠菓、スナック菓子、ビスケット、ゼリー、ジャム、クリーム、焼き菓子、パン等の菓子類;カニ、サケ、アサリ、マグロ、イワシ、エビ、カツオ、サバ、クジラ、カキ、サンマ、イカ、アカガイ、ホタテ、アワビ、ウニ、イクラ、トコブシ等の水産物;かまぼこ、ハム、ソーセージ等の水産・畜産加工食品;加工乳、発酵乳等の乳製品;サラダ油、てんぷら油、マーガリン、マヨネーズ、ショートニング、ホイップクリーム、ドレッシング等の油脂及び油脂加工食品;ソース、たれ等の調味料;カレー、シチュー、親子丼、お粥、雑炊、中華丼、かつ丼、天丼、うな丼、ハヤシライス、おでん、マーボドーフ、牛丼、ミートソース、玉子スープ、オムライス、餃子、シューマイ、ハンバーグ、ミートボール等のレトルトパウチ食品;種々の形態の健康食品や栄養補助食品;などが挙げられる。 There is no restriction | limiting in particular as said foodstuff, Although it can select suitably according to the objective, For example, drinks, such as a tea drink, a soft drink, a carbonated drink, a nutritive drink, a fruit drink, a lactic acid drink; Ice cream, ice sherbet , Shaved ice and other frozen desserts; buckwheat noodles such as noodles, udon noodles, harsame, gyoza zest, sushi mai, noodles such as Chinese noodles and instant noodles; rice cakes, candy, gum, chocolate, tablet confectionery, snacks, biscuits, jelly, jam, cream, Sweets such as baked goods and bread; crab, salmon, clams, tuna, sardines, shrimp, skipjack, mackerel, whale, oyster, saury, squid, red sea bream, scallop, abalone, sea urchin, sea bream, tocobushi, etc .; Processed fishery and livestock products such as ham and sausage; Dairy products such as processed milk and fermented milk; salad oil, tempura oil, margarine, mayonnaise, Fats and processed foods such as yotoning, whipped cream, dressing, etc .; seasonings such as sauces, sauces; curry, stew, oyakodon, rice cake, miscellaneous cooking, Chinese rice cakes, tempura, eel rice cake, hayashi rice, oden, marbodorf, Retort pouch foods such as beef bowl, meat sauce, egg soup, omelet rice, dumplings, shumai, hamburger and meatballs; various forms of health foods and dietary supplements.
(乳酸菌組成物)
本発明の乳酸菌組成物は、前記乳酸菌を含み、更に必要に応じてその他の成分を含有してなる。
ここで、前記乳酸菌組成物とは、人の健康に危害を加えるおそれが少なく、通常の社会生活において、経口又は消化管投与により摂取されるものをいい、行政区分上の食品、医薬品、医薬部外品、などの区分に制限されるものではなく、例えば、経口的に摂取される機能性食品、医薬部外品、医薬品などを幅広く含むものを意味する。
(Lactic acid bacteria composition)
The lactic acid bacteria composition of this invention contains the said lactic acid bacteria, and also contains another component as needed.
Here, the lactic acid bacteria composition is one that is less likely to harm human health and is taken by oral or gastrointestinal administration in normal social life. It is not limited to categories such as quasi-drugs, and includes, for example, a wide range of functional foods, quasi-drugs, and pharmaceuticals that are taken orally.
−乳酸菌−
前記乳酸菌組成物における前記乳酸菌としては、特に制限はなく、前記した本発明の乳酸菌の項目で記載した乳酸菌の中から適宜選択することができる。前記乳酸菌は、1種単独で使用してもよいし、2種以上を併用してもよい。前記乳酸菌組成物における前記乳酸菌の含有量としては、特に制限はなく、目的に応じて適宜選択することができる。また、前記乳酸菌組成物は、前記乳酸菌そのものであってもよい。
-Lactic acid bacteria-
There is no restriction | limiting in particular as said lactic acid bacteria in the said lactic acid bacteria composition, It can select suitably from the lactic acid bacteria described by the item of the lactic acid bacteria of the above-mentioned this invention. The said lactic acid bacteria may be used individually by 1 type, and may use 2 or more types together. There is no restriction | limiting in particular as content of the said lactic acid bacteria in the said lactic acid bacteria composition, According to the objective, it can select suitably. The lactic acid bacterium composition may be the lactic acid bacterium itself.
−その他の成分−
前記その他の成分としては、特に制限はなく、前記乳酸菌組成物の利用形態に応じて適宜選択することができるが、例えば、薬理学的に許容される担体が挙げられる。
前記担体としては、本発明の効果を損なわない限り、特に制限はなく、例えば、前記有効成分を各種の剤型として用いる場合において、その剤型に応じて適宜選択することができる。前記剤型としては、本発明の効果を損なわない限り、特に制限はなく、投与方法に応じて適宜選択することができ、例えば、経口固形剤(錠剤、被覆錠剤、顆粒剤、散剤、カプセル剤、トローチ剤など)、経口液剤(内服液剤、シロップ剤、エリキシル剤など)、などが挙げられる。
-Other ingredients-
There is no restriction | limiting in particular as said other component, Although it can select suitably according to the utilization form of the said lactic acid bacteria composition, For example, the support | carrier accept | permitted pharmacologically is mentioned.
The carrier is not particularly limited as long as the effects of the present invention are not impaired. For example, when the active ingredient is used in various dosage forms, it can be appropriately selected depending on the dosage form. The dosage form is not particularly limited as long as the effects of the present invention are not impaired, and can be appropriately selected depending on the administration method. For example, oral solids (tablets, coated tablets, granules, powders, capsules) , Lozenges, etc.), oral solutions (internal solutions, syrups, elixirs, etc.).
前記経口固形剤としては、例えば、前記乳酸菌に賦形剤、必要に応じて結合剤、崩壊剤、滑沢剤、着色剤、矯味・矯臭剤などの添加剤を加え、常法により製造することができる。
前記賦形剤としては、例えば、乳糖、白糖、塩化ナトリウム、ブドウ糖、デンプン、炭酸カルシウム、カオリン、微結晶セルロース、珪酸などが挙げられる。
As the oral solid preparation, for example, an excipient, and if necessary, additives such as a binder, a disintegrant, a lubricant, a coloring agent, a flavoring / flavoring agent, etc. are added to the lactic acid bacterium, and manufactured by a conventional method. Can do.
Examples of the excipient include lactose, sucrose, sodium chloride, glucose, starch, calcium carbonate, kaolin, microcrystalline cellulose, and silicic acid.
前記添加剤としては、本発明の効果を損なわない限り、特に制限はなく、目的に応じて適宜選択することができる。また、前記結合剤としては、例えば、水、エタノール、プロパノール、単シロップ、ブドウ糖液、デンプン液、ゼラチン液、カルボキシメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルスターチ、メチルセルロース、エチルセルロース、シェラック、リン酸カルシウム、ポリビニルピロリドンなどが挙げられ、前記崩壊剤としては、例えば、乾燥デンプン、アルギン酸ナトリウム、カンテン末、炭酸水素ナトリウム、炭酸カルシウム、ラウリル硫酸ナトリウム、ステアリン酸モノグリセリド、乳糖などが挙げられ、前記滑沢剤としては、例えば、精製タルク、ステアリン酸塩、ホウ砂、ポリエチレングリコールなどが挙げられ、前記着色剤としては、酸化チタン、酸化鉄などが挙げられ、前記矯味・矯臭剤としては、例えば、白糖、橙皮、クエン酸、酒石酸などが挙げられる。
また、前記乳酸菌の腸への定着補助を目的として、前記乳酸菌組成物にイヌリンを添加してもよい。
The additive is not particularly limited as long as the effects of the present invention are not impaired, and can be appropriately selected depending on the purpose. Examples of the binder include water, ethanol, propanol, simple syrup, glucose solution, starch solution, gelatin solution, carboxymethylcellulose, hydroxypropylcellulose, hydroxypropyl starch, methylcellulose, ethylcellulose, shellac, calcium phosphate, polyvinylpyrrolidone and the like. Examples of the disintegrant include dry starch, sodium alginate, agar powder, sodium bicarbonate, calcium carbonate, sodium lauryl sulfate, stearic acid monoglyceride, and lactose. Examples of the lubricant include , Purified talc, stearate, borax, polyethylene glycol and the like, and as the colorant, titanium oxide, iron oxide and the like, and as the flavoring and flavoring agent, If For example, white sugar, orange peel, citric acid, and tartaric acid.
Further, inulin may be added to the lactic acid bacteria composition for the purpose of assisting the colonization of the lactic acid bacteria in the intestine.
前記経口液剤としては、例えば、前記乳酸菌に、矯味・矯臭剤、緩衝剤、安定化剤などの添加剤を加え、常法により製造することができる。ここで、前記添加剤としては、本発明の効果を損なわない限り、特に制限はなく、目的に応じて適宜選択することができる。前記矯味・矯臭剤としては、例えば、白糖、橙皮、クエン酸、酒石酸などが挙げられ、緩衝剤としては、例えば、クエン酸ナトリウムなどが挙げられ、安定剤としては、例えば、トラガント、アラビアゴム、ゼラチンなどが挙げられる。 As the oral solution, for example, additives such as a taste-masking / flavoring agent, a buffering agent, a stabilizer and the like can be added to the lactic acid bacteria, and the oral solution can be produced by a conventional method. Here, the additive is not particularly limited as long as the effects of the present invention are not impaired, and can be appropriately selected according to the purpose. Examples of the flavoring / flavoring agent include sucrose, orange peel, citric acid, tartaric acid, and the like. Examples of the buffering agent include sodium citrate. Examples of the stabilizer include tragacanth and gum arabic. And gelatin.
前記乳酸菌組成物は、日常的に経口摂取することが可能であり、含有される前記乳酸菌の働きによって、強いタンナーゼ活性を効果的に発揮させることができるので、腸内において加水分解性タンニン及びガレート型カテキンのうち少なくとも1つを加水分解して、タンニン及びカテキン類のうち少なくとも1つの腸管からの吸収を促進することができる。
更に、前記乳酸菌組成物に含有される前記乳酸菌は、没食子酸脱炭酸酵素活性を有さないので、タンナーゼ活性により生成した没食子酸がピロガロールに変換されることがない。そのため、腸内で生成される没食子酸により優れた抗酸化作用が発揮される。更には、ピロガロールによる大腸癌などのリスクを低減することが期待される。
また、前記乳酸菌組成物は、日常的に経口摂取することが可能であり、含有される前記乳酸菌がイヌリン資化性を有しているので、経口摂取された後に腸内で増殖・定着しやすく、上記のタンナーゼ活性による作用を、腸内でより効果的に発揮させることができる。
The lactic acid bacterium composition can be taken orally on a daily basis, and can exert a strong tannase activity effectively by the action of the contained lactic acid bacterium. Therefore, hydrolyzable tannin and gallate in the intestine At least one of the type catechins can be hydrolyzed to promote absorption from the intestinal tract of at least one of the tannins and catechins.
Furthermore, since the lactic acid bacterium contained in the lactic acid bacterium composition does not have gallic acid decarboxylase activity, gallic acid produced by tannase activity is not converted to pyrogallol. Therefore, an excellent antioxidant action is exhibited by gallic acid produced in the intestine. Furthermore, it is expected to reduce the risk of colorectal cancer caused by pyrogallol.
In addition, the lactic acid bacteria composition can be taken orally on a daily basis, and the contained lactic acid bacteria have an inulin assimilation property, so that they easily grow and settle in the intestine after being taken orally. The action by the tannase activity can be more effectively exhibited in the intestine.
なお、本発明の植物エキス及び乳酸菌組成物は、ヒトに対して好適に適用されるものであるが、それぞれの作用効果が奏される限り、ヒト以外の動物に対して適用することもできる。 In addition, although the plant extract and lactic acid bacteria composition of this invention are suitably applied with respect to a human, as long as each effect is show | played, it can also be applied with respect to animals other than a human.
(植物エキスの製造方法)
本発明の植物エキスは、前記乳酸菌を用いて植物からの抽出物に含有される加水分解型タンニン及びガレート型カテキンのうち少なくとも1つを加水分解する工程を含み、更に必要に応じて、乳酸菌除去工程、植物からの抽出物の製造工程などの、その他の工程を含有してなる。
(Manufacturing method of plant extract)
The plant extract of the present invention includes a step of hydrolyzing at least one of hydrolyzed tannin and gallate catechin contained in an extract from a plant using the lactic acid bacterium, and further, if necessary, removing lactic acid bacterium It contains other processes, such as a process and the manufacturing process of the extract from a plant.
前記乳酸菌及び前記植物からの抽出物としては、特に制限はなく、前記した本発明の乳酸菌の項目で記載した乳酸菌及び植物からの抽出物の中から適宜選択することができる。
前記加水分解型タンニン及びガレート型カテキンのうち少なくとも1つを加水分解する方法としては、特に制限はなく、目的に応じて適宜選択することができるが、通常、前記乳酸菌と前記植物からの抽出物とを同一の溶液中に添加することによって行うことができる。前記加水分解の条件としても、特に制限はないが、前記乳酸菌の生育条件、前記乳酸菌が有する酵素活性の至適条件などを考慮して、適宜選択することができる。
The extract from the lactic acid bacterium and the plant is not particularly limited, and can be appropriately selected from the lactic acid bacterium and the extract from the plant described in the item of the lactic acid bacterium described above.
The method for hydrolyzing at least one of the hydrolyzed tannin and gallate catechin is not particularly limited and may be appropriately selected depending on the intended purpose. Usually, the extract from the lactic acid bacteria and the plant is used. Can be added to the same solution. The conditions for the hydrolysis are not particularly limited, and can be appropriately selected in consideration of the growth conditions for the lactic acid bacteria, the optimum conditions for the enzyme activity of the lactic acid bacteria, and the like.
なお、前記加水分解型タンニン及びガレート型カテキンのうち少なくとも1つを加水分解する工程において使用した前記乳酸菌は、前記植物エキスに含有されたままでもよく、除去されていてもよいが、前記乳酸菌自体が安全に摂取できて腸内で有益な点、及び、植物エキス製造時に特に乳酸菌除去工程を必要としない点で、前記植物エキスに含有されたままであることが好ましい。 The lactic acid bacterium used in the step of hydrolyzing at least one of the hydrolyzable tannin and gallate catechin may remain in the plant extract or may be removed, but the lactic acid bacterium itself Is preferably contained in the plant extract in that it can be safely ingested and is beneficial in the intestine, and does not require a lactic acid bacteria removal step when producing the plant extract.
前記植物エキスの製造方法によれば、製造に用いる前記乳酸菌が強いタンナーゼ活性を有しているので、前記植物からの抽出物に含有される加水分解型タンニン及びガレート型カテキンのうち少なくとも1つが加水分解されて、腸管から吸収されやすい植物エキスを製造することができる。更に、前記製造方法に用いる前記乳酸菌は、没食子酸脱炭酸酵素活性を有さないので、タンナーゼ活性により生成した没食子酸がピロガロールに変換されることがない。そのため、優れた抗酸化作用を有する低分子ポリフェノールを豊富に含む植物エキスを製造することができる。 According to the method for producing a plant extract, since the lactic acid bacterium used for production has a strong tannase activity, at least one of hydrolyzable tannin and gallate catechin contained in the extract from the plant is hydrolyzed. A plant extract that is decomposed and easily absorbed from the intestinal tract can be produced. Furthermore, since the lactic acid bacteria used in the production method do not have gallic acid decarboxylase activity, gallic acid produced by tannase activity is not converted to pyrogallol. Therefore, a plant extract containing abundant low molecular weight polyphenols having an excellent antioxidant action can be produced.
(低分子ポリフェノールの製造方法)
本発明の没食子酸の製造方法は、乳酸菌を用いて加水分解型タンニン、ガレート型カテキン及び没食子酸メチルのうち少なくとも1つを加水分解する工程を含み、更に必要に応じて、低分子ポリフェノール精製工程などのその他の工程を含有してなる。
(Production method of low molecular weight polyphenol)
The method for producing gallic acid of the present invention includes a step of hydrolyzing at least one of hydrolyzed tannin, gallate-type catechin and methyl gallate using lactic acid bacteria, and if necessary, a low molecular polyphenol purification step It contains other processes such as.
前記乳酸菌としては、特に制限はなく、前記した本発明の乳酸菌の項目で記載した乳酸菌の中から適宜選択することができる。
前記加水分解型タンニン、ガレート型カテキン及び没食子酸メチルのうち少なくとも1つを加水分解する方法としては、特に制限はなく、目的に応じて適宜選択することができるが、通常、前記乳酸菌と、前記加水分解型タンニン、ガレート型カテキン及び没食子酸メチルのうち少なくとも1つとを同一の溶液中に添加することによって行うことができる。前記加水分解の条件としても、特に制限はないが、前記乳酸菌の生育条件、前記乳酸菌が有する酵素活性の至適条件などを考慮して、適宜選択することができる。
There is no restriction | limiting in particular as said lactic acid bacteria, It can select suitably from the lactic acid bacteria described by the item of the lactic acid bacteria of this invention mentioned above.
The method for hydrolyzing at least one of the hydrolyzed tannin, gallate catechin and methyl gallate is not particularly limited and may be appropriately selected depending on the intended purpose. It can be performed by adding at least one of hydrolyzed tannin, gallate catechin and methyl gallate in the same solution. The conditions for the hydrolysis are not particularly limited, and can be appropriately selected in consideration of the growth conditions for the lactic acid bacteria, the optimum conditions for the enzyme activity of the lactic acid bacteria, and the like.
前記低分子ポリフェノールとしては、前記加水分解型タンニン、ガレート型カテキン及び没食子酸メチルのうち少なくとも1つを基質としてタンナーゼ処理することにより製造可能な、低分子ポリフェノールである限り、特に制限はなく、例えば、没食子酸、エラグ酸などが挙げられる。 The low molecular weight polyphenol is not particularly limited as long as it is a low molecular weight polyphenol that can be produced by a tannase treatment using at least one of the hydrolyzed tannin, gallate catechin, and methyl gallate as a substrate. , Gallic acid, ellagic acid and the like.
前記低分子ポリフェノールの製造方法によれば、製造に用いる前記乳酸菌が強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さないので、低分子ポリフェノールを効率的に製造することができる。また、前記乳酸菌は、漬物から単離された菌であり安全性が高いので、低分子ポリフェノールの製造に用いた反応液をそのまま又は簡易な処理を施した後に、排水として流すことができる点でも有利である。 According to the method for producing the low molecular weight polyphenol, the lactic acid bacterium used for the production has a strong tannase activity and does not have a gallic acid decarboxylase activity. Therefore, the low molecular weight polyphenol can be produced efficiently. In addition, since the lactic acid bacterium is a bacterium isolated from pickles and highly safe, the reaction solution used for the production of the low molecular weight polyphenol can be allowed to flow as waste water as it is or after simple treatment. It is advantageous.
以下に本発明の実施例を説明するが、本発明は、これらの実施例に何ら限定されるものではない。 Examples of the present invention will be described below, but the present invention is not limited to these examples.
(実施例1)
−菌株の同定−
漬物から単離された22A−1株,22A−3株及び22B−2株から、公知の手法により染色体DNAを抽出し、Dongらの論文(Dong,X.,Xin,Y.,Jian,W.,Liu,X.,Ling,D.(2000).Bifidobacterium thermacidophilum sp.nov.,isolated from an anaerobic digester. International Journal of Systematic and Evolutional Microbiology 50,199−125)に記載されている細菌全菌種に共通反応するプライマー 27f(5‘−AGAGTTTGATCC/ATGGCTCAG−3’)及び1541R(5‘−AAGGAGGTGATCCAGCC−3’)を用いてPCRを行い、16S rDNAをほぼ網羅する領域を増幅した。
Example 1
-Identification of strains-
Chromosomal DNA was extracted from the 22A-1 strain, 22A-3 strain and 22B-2 strain isolated from pickles by a known method, and Dong et al. (Dong, X., Xin, Y., Jian, W , Liu, X., Ling, D. (2000) .Bifidobacterium thermophilum sp.nov., Isolated from ananalogous digester.Internal Journal of Systemic 50. 27f (5'-AGAGTTTGATCC / ATGGCTCAG-3 ') and 1541R (5'-AAGGAGGTGATCCAGC) PCR was performed using the 3 ') was amplified a region that substantially covers the 16S rDNA.
得られた約1.6kbのPCR産物をpGEM−T EASY Vector(Promega)に挿入し、ヒートショック法にてコンピテント細胞DH5αに導入し、Xgal−Ampicilin添加LB平板培地にてカラースクリーニングを行った。選択した白色コロニーよりプラスミドを抽出し、pGEM−T EASY Vectorの配列を基に設計したプライマーSP6(5‘TATTTAGGTGACACTATAG−3’)、T7(5‘−TAATACGACTCACTATAGGG−3’)を用いて前記PCR産物(16S rDNA)のシークエンスを決定した(22A−1株:配列番号1、22A−3株:配列番号2、22B−2株:配列番号3)。 The obtained PCR product of about 1.6 kb was inserted into pGEM-T EASY Vector (Promega), introduced into competent cells DH5α by the heat shock method, and color screening was performed on LB plate medium supplemented with Xgal-Amiciliin. . A plasmid was extracted from the selected white colonies, and the PCR product (5′-TAATTAGACTACTACTATAGGG-3 ′) and T7 (5′-TAATACGACTCACTATATAGGG-3 ′) designed based on the sequence of pGEM-T EASY Vector were used. 16S rDNA) was determined (22A-1 strain: SEQ ID NO: 1, 22A-3 strain: SEQ ID NO: 2, 22B-2 strain: SEQ ID NO: 3).
DNAデータベース(DDBJ)にアクセスして、FASTAプログラムを用いて、16S rDNAの塩基配列の相同性検索を行った結果、22A−1株,22A−3株及び22B−2株の16S rDNA塩基配列は、いずれも、従来公知のラクトバシルス・プランタラム WCFS1株の16S rDNA塩基配列(配列番号4)と高い相同性を有していた。結果を表3に示す。
また、22A−1株,22A−3株及び22B−2株が、16S rDNA塩基配列においてラクトバシルス・プランタラムと非常に近似しているラクトバシルス・パラプランタラム(Lactobacillus plantarum)及びラクトバシルス・ペントサス(Lactobacillus pentosus)ではないことを確認するため、ラクトバシルス・プランタラムの16S/23S rDNA スペーサー領域の種特異的配列に注目したBerthierらの論文(Berthier,F.,Ehrhich,S.D.(1998).Rapid species identification within two groups of closely related lactobacilli using PCR primers that target the16S/23S rRNA spacer region.FEMS Microbiologilcal Letters 161,97−106)に記載されているPCR法を用いて種の同定を行った結果、22A−1株,22A−3株及び22B−2株は全て、ラクトバシルス・プランタラムであることが確認された。 In addition, the 22A-1 strain, 22A-3 strain and 22B-2 strain are Lactobacillus plantarum and Lactobacillus pentosus which are very similar to Lactobacillus plantarum in 16S rDNA base sequence. In order to confirm that the 16S / 23S rDNA spacer region of Lactobacillus plantarum has been examined, Berthier et al. (Bertier, F., Ehrhich, SD (1998). Rapid specifications) identification with two groups of closed relaxed using PC As a result of species identification using the PCR method described in Primers that target the 16S / 23S rRNA spacer region. FEMS Microbiological Letters 161, 97-106), 22A-1 strain, 22A-3 strain and 22B-2 All strains were confirmed to be Lactobacillus plantarum.
(実施例2)
−定性的タンナーゼ試験−
22A−1株,22A−3株及び22B−2株について、下記の試験法により、定性的タンナーゼ試験を行った。この試験法は、Osawaらの論文(Osawa,R.,and T.P.Walsh(1993).A visual reading method for detection of bacterial tannase.Applied and Environmental Microbiology,59:1251−1252.)に記載の方法に準拠するものである。
リン酸二水素ナトリウム(33mM;Wako)とタンニン様の構造を持つ没食子酸メチル(20mM;Aldrich Chemical Compan,Inc.,Milwaukee,U.S.A)を含むpH5.0に調整した溶液を、滅菌フィルター(孔径0.45μm;Millipore Co.,Bedford,U.S.A.)を用いて試験管に5mlずつ無菌的に分注して基質培地とした。MRS寒天平板培地で37℃、24時間培養した被験菌群を滅菌綿棒で掻き取り、上述の基質培地に懸濁させ、O.D.660nmでの吸光度が0.4となるように調整した。これを37℃、24時間で静置培養した。培養後、よく懸濁した培養液1mlを採取して小試験管に移し、予め用意しておいた飽和炭酸水素ナトリウム(Wako)溶液(pH8.6)を等量加えてアルカリ化させ、室温で静置した。30分後に溶液が緑又は茶色に発色したものをタンナーゼ陽性とした。
定性的タンナーゼ試験の結果、22A−1株,22A−3株及び22B−2株の全てに、タンナーゼ活性が認められた。
(Example 2)
-Qualitative tannase test-
The 22A-1 strain, 22A-3 strain and 22B-2 strain were subjected to a qualitative tannase test by the following test method. This test method is described in Osawa et al. (Osawa, R., and T.P. Walsh (1993). A visual reading method for detection of bacterial tannase. Applied and Environmental Micro 125. 125). It is based on the method.
A solution adjusted to pH 5.0 containing sodium dihydrogen phosphate (33 mM; Wako) and methyl gallate (20 mM; Aldrich Chemical Company, Inc., Milwaukee, USA) having a tannin-like structure is sterilized. Using a filter (pore size 0.45 μm; Millipore Co., Bedford, USA), 5 ml each was aseptically dispensed into a test tube to obtain a substrate medium. The test bacteria group cultured for 24 hours at 37 ° C. on MRS agar plate medium was scraped with a sterile cotton swab, suspended in the above-mentioned substrate medium, and O.D. D. The absorbance at 660 nm was adjusted to 0.4. This was statically cultured at 37 ° C. for 24 hours. After culturing, 1 ml of the well-suspended culture solution is collected and transferred to a small test tube, and alkalinized by adding an equal amount of a saturated sodium bicarbonate (Wako) solution (pH 8.6) prepared in advance. Left to stand. A solution colored green or brown after 30 minutes was defined as tannase positive.
As a result of the qualitative tannase test, tannase activity was observed in all of the 22A-1 strain, 22A-3 strain and 22B-2 strain.
(実施例3)
−定性的没食子酸脱炭酸酵素試験−
22A−1株,22A−3株及び22B−2株について、下記の試験法により、定性的没食子酸脱炭酸酵素試験を行った。この試験法は、Osawaらの論文(Osawa,R.,and T.P.Walsh(1995).Detection of bacterial gallate decarboxylation by visual color discrimination.Journal of General and Applied Microbiology.41:165−170.)に記載の方法に準拠するものである。
5mlのMRS液体培地に、滅菌フィルター(孔径0.45μm)を用いて予め用意した100mM没食子酸(Wako)溶液(pH5.0)を最終濃度10mMになるように無菌的に添加してよく混合した。この溶液に、MRS寒天培地に増殖した新鮮分離菌株を1コロニー釣菌し、接種して37℃、24時間嫌気培養した。培養後、培養液を1ml採取して小試験管に移し、飽和炭酸水素ナトリウム溶液(pH8.6)を等量加えてアルカリ化させ、室温で静置した。30分後に溶液が鮮やかな橙色に変色すれば、GDase陽性、深い緑色又は褐色に変色すればGDase陰性とした。橙色に変色すれば、没食子酸が脱炭酸され、代謝産物であるピロガロールが存在することを示すとされている。
定性的没食子酸脱炭酸酵素試験の結果、22A−1株,22A−3株及び22B−2株のいずれにも、没食子酸脱炭酸酵素活性が認められなかった。
(Example 3)
-Qualitative gallic acid decarboxylase test-
The 22A-1 strain, 22A-3 strain, and 22B-2 strain were subjected to a qualitative gallic acid decarboxylase test by the following test method. This test method is described in Osawa et al. (Osawa, R., and T.P. Walsh (1995). Detection of bacterial gallate decylation by visual color discriminating. It complies with the described method.
To 5 ml of MRS liquid medium, 100 mM gallic acid (Wako) solution (pH 5.0) prepared in advance using a sterile filter (pore size 0.45 μm) was aseptically added to a final concentration of 10 mM and mixed well. . This solution was inoculated with 1 colony of freshly isolated strain grown on MRS agar medium, inoculated and anaerobically cultured at 37 ° C. for 24 hours. After culturing, 1 ml of the culture solution was collected and transferred to a small test tube, added with an equal volume of saturated sodium hydrogen carbonate solution (pH 8.6) to be alkalized, and allowed to stand at room temperature. When the solution turned bright orange after 30 minutes, GDase was positive, and when the solution turned deep green or brown, it was regarded as GDase negative. If the color changes to orange, gallic acid is decarboxylated, indicating that the metabolite pyrogallol is present.
As a result of the qualitative gallic acid decarboxylase test, gallic acid decarboxylase activity was not observed in any of the 22A-1 strain, 22A-3 strain and 22B-2 strain.
(実施例4)
−定量的タンナーゼ試験−
22A−1株,22A−3株及び22B−2株について、下記の試験法により、定量的没食子酸脱炭酸酵素試験を行った。この試験法は、Nishitaniらの論文(Nishitani,Y.,Osawa,R.(2003).A novel colorimetric method to quantify tannase activity of viable bacteria.Journal of Microbiological Methods 54(2):281−284.)に記載の方法に準拠するものである。
Example 4
-Quantitative tannase test-
The 22A-1 strain, the 22A-3 strain, and the 22B-2 strain were subjected to a quantitative gallic acid decarboxylase test by the following test method. This test method is described in a paper by Nishitani et al. (Nishitani, Y., Osawa, R. (2003). A novel colorimetric method to quantative activity of 28.Mour.our.Jour. It complies with the described method.
まず、アスペルギルス・オリゼ由来のタンナーゼ(Wako)と、リン酸二水素ナトリウム(33mM;Wako)を含むpH5.0に調整した溶液を酵素溶液として、検量線の作成に用いた。このとき、酵素溶液に含まれるアスペルギルス・オリゼ由来のタンナーゼ(Wako)の濃度を変えて、タンナーゼの濃度が0.63〜1000mUの酵素溶液を調製した。酵素溶液から50μLずつ分取し、予め用意しておいた基質溶液(没食子酸メチル(5mM;Aldrich Chemical Compan,Inc.,Milwaukee,U.S.A)、リン酸二水素ナトリウム(33mM;Wako)、pH5.0)を5mL加えて混合した。これを37℃、24時間静置した。静置後、100μLを分取し、予め用意しておいた飽和炭酸水素ナトリウム(Wako)溶液(pH8.6)を等量加えてアルカリ化させ、37℃で2時間静置した。静置後、よく攪拌し、8,000×gで20秒間遠心した。上清から100μLを96穴マイクロプレートに分取し、マイクロプレートリーダー(Model 550、Bio−Rad社)を用いてO.D.450nmの吸光度を測定した。得られた吸光度から、検量線を作成した。 First, a solution adjusted to pH 5.0 containing tannase (Wako) derived from Aspergillus oryzae and sodium dihydrogen phosphate (33 mM; Wako) was used as an enzyme solution to prepare a calibration curve. At this time, the concentration of tannase derived from Aspergillus oryzae (Wako) contained in the enzyme solution was changed to prepare an enzyme solution having a tannase concentration of 0.63 to 1000 mU. 50 μL each from the enzyme solution was prepared and prepared in advance (methyl gallate (5 mM; Aldrich Chemical Company, Inc., Milwaukee, USA), sodium dihydrogen phosphate (33 mM; Wako)) , PH 5.0) was added and mixed. This was left still at 37 ° C. for 24 hours. After allowing to stand, 100 μL was taken out, made equal by adding an equal amount of a saturated sodium hydrogen carbonate (Wako) solution (pH 8.6) prepared in advance, and allowed to stand at 37 ° C. for 2 hours. After standing, the mixture was stirred well and centrifuged at 8,000 × g for 20 seconds. 100 μL of the supernatant was dispensed into a 96-well microplate, and O.D. was obtained using a microplate reader (Model 550, Bio-Rad). D. Absorbance at 450 nm was measured. A calibration curve was prepared from the obtained absorbance.
次に、リン酸二水素ナトリウム(33mM;Wako)とタンニン様の構造を持つ没食子酸メチル(5mM;Aldrich Chemical Compan,Inc.,Milwaukee,U.S.A)を含むpH5.0に調整した溶液を、滅菌フィルター(孔径0.45μm;Millipore Co.,Bedford,U.S.A.)を用いて試験管に1mlずつ無菌的に分注して基質培地とした。MRS寒天平板培地で37℃、24時間培養した被験菌群を滅菌綿棒で掻き取り、上述の基質培地に懸濁させ、O.D.660nmでの吸光度が0.4となるように調整した。これを37℃、24時間で静置培養した。培養後、よく懸濁した培養液1mlを採取してエッペンチューブに移し、8,000×gで5分間遠心した。上清を100μL分取し、予め用意しておいた飽和炭酸水素ナトリウム(Wako)溶液(pH8.6)を等量加えてアルカリ化させ、37℃で2時間静置した。静置後、よく攪拌し、8,000×gで20秒間遠心した。上清から100μLを96穴マイクロプレートに分取し、マイクロプレートリーダー(Model 550、Bio−Rad社)を用いてO.D.450nmの吸光度を測定した。得られた吸光度から、前記検量線に基づいて、タンナーゼ活性(mU/mL)を求めた。 Next, a solution adjusted to pH 5.0 containing sodium dihydrogen phosphate (33 mM; Wako) and methyl gallate (5 mM; Aldrich Chemical Company, Inc., Milwaukee, USA) having a tannin-like structure Was aseptically dispensed 1 ml each into a test tube using a sterilizing filter (pore size 0.45 μm; Millipore Co., Bedford, USA) to obtain a substrate medium. The test bacteria group cultured on MRS agar plate medium at 37 ° C. for 24 hours was scraped with a sterile cotton swab and suspended in the above-mentioned substrate medium. D. The absorbance at 660 nm was adjusted to 0.4. This was statically cultured at 37 ° C. for 24 hours. After the culture, 1 ml of the well-suspended culture solution was collected and transferred to an Eppendorf tube, and centrifuged at 8,000 × g for 5 minutes. 100 μL of the supernatant was collected, made equal by adding an equal amount of a saturated sodium bicarbonate (Wako) solution (pH 8.6) prepared in advance, and allowed to stand at 37 ° C. for 2 hours. After standing, the mixture was stirred well and centrifuged at 8,000 × g for 20 seconds. 100 μL of the supernatant was dispensed into a 96-well microplate, and O.D. was obtained using a microplate reader (Model 550, Bio-Rad). D. Absorbance at 450 nm was measured. Based on the obtained calibration curve, tannase activity (mU / mL) was determined from the obtained absorbance.
定量的タンナーゼ試験の結果、22A−1株、22A−3株及び22B−2株のタンナーゼ活性は、それぞれ、6.64、7.18、6.95mU/mLであった。
即ち、22A−1株、22A−3株及び22B−2株のタンナーゼ活性は、前記Nishitaniらの論文に記載のいずれのラクトバシルス・プランタラム株のタンナーゼ活性(最大で5.73mU/mL(ATCC 14917株))よりも高い値であることが示された。
また、22A−1株、22A−3株及び22B−2株のタンナーゼ活性を、前記Nishitaniらの論文に記載のラクトバシルス・プランタラム株の中で、タンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さないラクトバシルス・プランタラム株のタンナーゼ活性(最大で1.52mU/mL(KOG11株))と比較すると、著しく高いことが示された。
As a result of the quantitative tannase test, the tannase activities of the 22A-1 strain, the 22A-3 strain, and the 22B-2 strain were 6.64, 7.18, and 6.95 mU / mL, respectively.
That is, the tannase activity of 22A-1 strain, 22A-3 strain, and 22B-2 strain is the same as that of any Lactobacillus plantarum strain described in the aforementioned Nishitani et al. Paper (maximum 5.73 mU / mL (ATCC 14917). It was shown to be higher than that of the stock)).
Further, the tannase activity of 22A-1 strain, 22A-3 strain and 22B-2 strain has tannase activity among the Lactobacillus plantarum strains described in the above-mentioned Nishitani et al. Paper, and has gallic acid decarboxylase activity. Compared with the tannase activity (up to 1.52 mU / mL (KOG11 strain)) of the Lactobacillus plantarum strain having no E. coli, it was shown to be remarkably high.
本発明の乳酸菌は、強いタンナーゼ活性を有し、没食子酸脱炭酸酵素活性を有さず、腸で好適に定着でき、安全に摂取できるので、例えば、腸内細菌叢の改善を目的とした乳酸菌組成物として利用することができる。また、本発明の乳酸菌を植物からの抽出物に添加することにより、植物に含有される加水分解型タンニン及びガレート型カテキンのうち少なくとも1つを加水分解することができるので、腸からの吸収に優れた植物エキスを提供することができる。前記植物エキスは、食品、医薬、化合物の製造など、分野を問わず幅広く利用することができる。 The lactic acid bacterium of the present invention has strong tannase activity, does not have gallic acid decarboxylase activity, can be suitably established in the intestine, and can be safely ingested, for example, lactic acid bacterium for the purpose of improving intestinal flora It can be used as a composition. Further, by adding the lactic acid bacterium of the present invention to an extract from a plant, at least one of hydrolyzable tannin and gallate catechin contained in the plant can be hydrolyzed. An excellent plant extract can be provided. The plant extract can be widely used regardless of the field such as food, medicine and compound production.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007299592A JP5162212B2 (en) | 2007-11-19 | 2007-11-19 | Novel lactic acid bacteria, lactic acid bacteria composition and plant extract, and method for producing plant extract and low molecular weight polyphenol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007299592A JP5162212B2 (en) | 2007-11-19 | 2007-11-19 | Novel lactic acid bacteria, lactic acid bacteria composition and plant extract, and method for producing plant extract and low molecular weight polyphenol |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009124943A true JP2009124943A (en) | 2009-06-11 |
JP5162212B2 JP5162212B2 (en) | 2013-03-13 |
Family
ID=40816480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007299592A Active JP5162212B2 (en) | 2007-11-19 | 2007-11-19 | Novel lactic acid bacteria, lactic acid bacteria composition and plant extract, and method for producing plant extract and low molecular weight polyphenol |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5162212B2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011518570A (en) * | 2008-04-30 | 2011-06-30 | ネステク ソシエテ アノニム | Products containing decarboxylated phenolic acid derived from coffee chlorogenic acid and use thereof |
JP2012100655A (en) * | 2010-10-15 | 2012-05-31 | National Agriculture & Food Research Organization | Microorganism and composition containing catecholamine selected based on recognition of catecholamine as indicator |
JP2014031325A (en) * | 2012-08-02 | 2014-02-20 | Maruzen Pharmaceut Co Ltd | Anti-inflammatory agent |
CN104178552A (en) * | 2014-07-28 | 2014-12-03 | 中国林业科学研究院林产化学工业研究所 | Method for screening out strain for generating gallic acid decarboxylase (GAD) at high yield and preparing pyrogallic acid by degrading gallic acid |
CN105942527A (en) * | 2016-05-18 | 2016-09-21 | 田雷 | Probiotics and prebiotics compound preparation as well as preparation method and application thereof |
JP2017114814A (en) * | 2015-12-24 | 2017-06-29 | 丸善製薬株式会社 | Cosmetics |
JP2019178123A (en) * | 2018-03-30 | 2019-10-17 | 丸善製薬株式会社 | Glycyrrhiza extract fermented product, whitening agent, anti-aging agent, skin cosmetic and food and drink |
JP2020058311A (en) * | 2018-10-12 | 2020-04-16 | 株式会社東洋新薬 | Oral composition |
JP2020203930A (en) * | 2020-09-09 | 2020-12-24 | 丸善製薬株式会社 | Cosmetics |
CN113424869A (en) * | 2021-04-30 | 2021-09-24 | 宁波益富乐生物科技有限公司 | Preparation method of low-sugar lactobacillus beverage and product thereof |
JP2022506748A (en) * | 2018-11-05 | 2022-01-17 | マーベルバイオーム・インコーポレイテッド | Microbial composition containing ellagitannin and how to use |
CN113980858A (en) * | 2021-11-18 | 2022-01-28 | 上海植酵盛生物科技有限公司 | Lactobacillus plantarum YL399 for producing high-activity tannase and application thereof in preparation of codonopsis pilosula fermented feed |
CN115067516A (en) * | 2022-08-23 | 2022-09-20 | 山东凤凰生物科技股份有限公司 | Application of lactobacillus plantarum BLCC2-0015, peony fermentation broth and application thereof |
CN117384879A (en) * | 2023-01-13 | 2024-01-12 | 中国农业科学院茶叶研究所 | A method for preparing acid-resistant tanninase adapted to tea juice system |
-
2007
- 2007-11-19 JP JP2007299592A patent/JP5162212B2/en active Active
Non-Patent Citations (4)
Title |
---|
JPN6012064711; 'Isolation of Tannin-Degrading Lactobacilli from Humans and Fermented Foods' Appl. Environ. Microbiol. Vol. 66, No. 7, 2000, p. 3093-3097 * |
JPN6012064713; 'Genotypic Analyses of Lactobacilli with a Range of Tannase Activities Isolated from Human Feces and' Systematic and Applied Microbiology Vol. 27, No. 1, 2004, p. 109-117 * |
JPN6012064715; 'Tannase activity by lactic acid bacteria isolated from grape must and wine' International Journal of Food Microbiology Vol. 96, 2004, p. 199-204 * |
JPN6012064717; 'Isolation of tannin-degrading bacteria isolated from feces of the Japanese large wood mouse, Apodemu' Systematic and Applied Microbiology Vol. 28, No. 4, 2005, p. 358-365 * |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011518570A (en) * | 2008-04-30 | 2011-06-30 | ネステク ソシエテ アノニム | Products containing decarboxylated phenolic acid derived from coffee chlorogenic acid and use thereof |
JP2012100655A (en) * | 2010-10-15 | 2012-05-31 | National Agriculture & Food Research Organization | Microorganism and composition containing catecholamine selected based on recognition of catecholamine as indicator |
JP2014031325A (en) * | 2012-08-02 | 2014-02-20 | Maruzen Pharmaceut Co Ltd | Anti-inflammatory agent |
CN104178552A (en) * | 2014-07-28 | 2014-12-03 | 中国林业科学研究院林产化学工业研究所 | Method for screening out strain for generating gallic acid decarboxylase (GAD) at high yield and preparing pyrogallic acid by degrading gallic acid |
JP2017114814A (en) * | 2015-12-24 | 2017-06-29 | 丸善製薬株式会社 | Cosmetics |
CN105942527A (en) * | 2016-05-18 | 2016-09-21 | 田雷 | Probiotics and prebiotics compound preparation as well as preparation method and application thereof |
JP2022125278A (en) * | 2018-03-30 | 2022-08-26 | 丸善製薬株式会社 | PROFILAGGRIN mRNA EXPRESSION PROMOTER, SERINE PALMITOYL TRANSFERASE mRNA EXPRESSION PROMOTER, HYALURONIC ACID SYNTHASE 3 mRNA EXPRESSION PROMOTER, AND ANTI-AGING AGENT |
JP2019178123A (en) * | 2018-03-30 | 2019-10-17 | 丸善製薬株式会社 | Glycyrrhiza extract fermented product, whitening agent, anti-aging agent, skin cosmetic and food and drink |
JP7458660B2 (en) | 2018-03-30 | 2024-04-01 | 丸善製薬株式会社 | Profilaggrin mRNA expression promoter, serine palmitoyltransferase mRNA expression promoter, and hyaluronic acid synthase 3 mRNA expression promoter |
JP2020058311A (en) * | 2018-10-12 | 2020-04-16 | 株式会社東洋新薬 | Oral composition |
JP7248272B2 (en) | 2018-10-12 | 2023-03-29 | 株式会社東洋新薬 | oral composition |
JP2022506748A (en) * | 2018-11-05 | 2022-01-17 | マーベルバイオーム・インコーポレイテッド | Microbial composition containing ellagitannin and how to use |
JP7638866B2 (en) | 2018-11-05 | 2025-03-04 | マーベルバイオーム・インコーポレイテッド | Microbial Compositions Comprising Ellagitannins and Methods of Use |
JP7082827B2 (en) | 2020-09-09 | 2022-06-09 | 丸善製薬株式会社 | Cosmetics |
JP2020203930A (en) * | 2020-09-09 | 2020-12-24 | 丸善製薬株式会社 | Cosmetics |
CN113424869B (en) * | 2021-04-30 | 2022-06-03 | 宁波益富乐生物科技有限公司 | Preparation method of low-sugar lactobacillus beverage and product thereof |
CN113424869A (en) * | 2021-04-30 | 2021-09-24 | 宁波益富乐生物科技有限公司 | Preparation method of low-sugar lactobacillus beverage and product thereof |
CN113980858A (en) * | 2021-11-18 | 2022-01-28 | 上海植酵盛生物科技有限公司 | Lactobacillus plantarum YL399 for producing high-activity tannase and application thereof in preparation of codonopsis pilosula fermented feed |
CN115067516A (en) * | 2022-08-23 | 2022-09-20 | 山东凤凰生物科技股份有限公司 | Application of lactobacillus plantarum BLCC2-0015, peony fermentation broth and application thereof |
CN115067516B (en) * | 2022-08-23 | 2022-11-25 | 山东凤凰生物科技股份有限公司 | Application of lactobacillus plantarum BLCC2-0015, peony fermentation broth and application thereof |
CN117384879A (en) * | 2023-01-13 | 2024-01-12 | 中国农业科学院茶叶研究所 | A method for preparing acid-resistant tanninase adapted to tea juice system |
CN117384879B (en) * | 2023-01-13 | 2024-04-30 | 中国农业科学院茶叶研究所 | A method for preparing acid-resistant tannase suitable for tea juice system |
Also Published As
Publication number | Publication date |
---|---|
JP5162212B2 (en) | 2013-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5162212B2 (en) | Novel lactic acid bacteria, lactic acid bacteria composition and plant extract, and method for producing plant extract and low molecular weight polyphenol | |
KR101825836B1 (en) | Novel Lactobacillus plantarum Lb41 strain and compositions for the prevention and treatment of diabetes or insulin resistance syndrome containing the same | |
KR102028744B1 (en) | Lactobacillus plantarum HY7717 strain having immune-enhancing activity, antioxidative activity and digestive fluid resistance and use thereof | |
JP2017536093A (en) | Method for producing microbial preparation and microbial preparation produced thereby | |
KR101868517B1 (en) | Lactobacillus fermentum PL9119 with biofunctional activities and high heat stability as a probiotic without antibiotic resistance | |
KR101381547B1 (en) | Novel Leuconostoc mesenteroides from kimchi with inhibiting activities on pathogenic microorganism and use thereof | |
US12263195B2 (en) | Microbiological process for the production of bee bread | |
KR20160132050A (en) | Novel lactobacillus paracasei strain | |
JP2022001590A (en) | Anti-obesity agent, cosmetic product, and food and drink products | |
KR102677848B1 (en) | Probiotics for fermenting kimchi and kimchi using the same | |
KR101825837B1 (en) | Novel Lactobacillus plantarum Ln4 strain and compositions for the prevention and treatment of diabetes or insulin resistance syndrome containing the same | |
Kim et al. | Preparation and characterization of fermented dandelion (Taraxacum officinale) beverage using Lactobacillus acidophilus F46 having cinnamoyl esterase activity | |
WO2007052806A1 (en) | Method of producing gaba-containing fermented product | |
KR101091833B1 (en) | Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria | |
CN116948884A (en) | Lactobacillus delbrueckii subspecies with high biofilm formation and strong stress resistance and application thereof | |
KR20210062801A (en) | Lactobacillus Plantarum YG1102 Strain Having Antimicrobial and Anti-Obesity Activity and Uses thereof | |
Zhou et al. | Probiotic properties of Lactobacillus paraplantarum LS-5 and its effect on antioxidant activity of fermented sauerkraut | |
KR102183841B1 (en) | Novel Lactobacillus plantarum Ln4 strain and compositions for the prevention and treatment of obesity containing the same | |
KR102548092B1 (en) | Lactobacillus curvatus OKBL-L.CU 1 strain having antioxidant activity, antimicrobial activity, skin whitening activity, skin anti-wrinkle activity, anti-inflammatory activity and anti-cancer activity and uses thereof | |
KR101627806B1 (en) | The culturing method for increasing immune-enhancing activity in Lactobacillus spp. | |
Hossain et al. | Antipathogenic action and antibiotic sensitivity pattern of the “Borhani”-associated lactic acid bacterium Weissella confusa LAB-11 | |
KR20180040894A (en) | Novel Lactobacillus plantarum Lb41 strain and compositions for the prevention and treatment of obesity containing the same | |
KR102190239B1 (en) | Novel Lactobacillus plantarum Lb41 strain and compositions for the prevention and treatment of obesity containing the same | |
KR20190122187A (en) | Novel Lactobacillus plantarum Lb41 strain and compositions for the prevention and treatment of obesity containing the same | |
KR20160083781A (en) | Method for preparing fermented citrus composition with improved bioactivity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20101116 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120918 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121116 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121211 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121217 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5162212 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151221 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |